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Summary 
The work presented here demonstrates new insights into the assembly mechanisms of the 
nuclear lamina. By generation and expression of several lamin mutants in mammalian cells it 
was possible to analyze the influence of distinct lamin domains on cellular localization and 
their assembly properties. Both partial and complete head deleted lamin B2 localized to the 
nuclear rim but highly impaired nuclear shape indicating that the head domain is dispensable 
for nuclear envelope localization and however, important for efficient lamin assembly. In 
contrast, tail deleted lamin B2 mutants did not incorporate into the nuclear rim and were 
distributed throughout the cytoplasm and the nucleoplasm. This suggests that the tail 
domain contains those elements that are necessary for effectively guiding these lamins to 
the nuclear envelope. However, tailless mutants did not impair the formation of a nuclear 
lamina. An exhaustive mutation trial of the individual mitotic phosphoacceptor sites flanking 
the central rod domain from serine to aspartic acid was performed in order to test if this 
would still allow the integration of these mutants into the nuclear lamina and if this would 
lead to the disassembly of the nuclear lamina. Notably, the mutant proteins were not 
incorporated into the lamina at all but instead they formed intranuclear aggregates when 
expressed in U2OS cells. Interestingly, the effect of nuclear aggregate formation was 
independent of both the position of the mutated site and the number of sites mutated. Live 
cell imaging experiments showed that the aggregates are rather dynamic structures that are 
able to fuse and occupy single large lamin territories. Co-transfection studies of “mitotic” 
lamin B1, “mitotic” lamin B2 and NLS-vimentin suggest that the aggregates are deposited in 
the interchromosomal domain compartment (ICD). However, intermingling of the proteins 
was not observed. Extraction experiments revealed that the aggregates were rather loosely 
connected to the nuclear matrix. Although the mechanism underlying aggregate formation of 
“mitotic” lamin B1, “mitotic” lamin B2, and NLS-vimentin remains elusive, our results strongly 
suggest the existence of nuclear “protein processing centers”. Their functions may relate to 
the prevention of macromolecular crowding as well as to the organization and distribution of 
nuclear proteins in general.  
Wild type and mutant lamins were also expressed in mouse embryonic stem (ES) cells. Their 
ability to differentiate into all specialized cell types found in the adult mouse and the 
exhibition and maintenance of a normal diploid complement of chromosomes make them a 
valuable tool for cell biological studies. As expected, both wild type lamin B1 and wild type 
lamin B2 localized to the nuclear rim. The stem cell status of the cells was not affected. 
Expression of lamin B2 deletion mutants in mouse ES cells showed similar effects as those 
observed in U2OS cells suggesting that lamin proteins are similarly processed and assembled 
into the nuclear lamina in both differentiated and ES cells.  
Additionally, a novel nonsense mutation in the lamin A gene (pR321X) cosegregating with 
dilated cardiomyopathy and cardiac rhythm disturbances was analyzed in both cultivated 
cells and cardiac tissue of affected patients. Neither nuclear abnormalities nor reduced 
  
expression of the wild type protein was observed. In line with a strong nonsense-mediated 
mRNA decay (NMD), i.e. the NMD-dependent reduction in the relative amount of mutant 
mRNA, the truncated protein was not found. The potential transient presence of this mutant 
protein could be uncovered, however, by inhibition of the proteasomal system. It is therefore 
suggested that NMD is not sufficient to completely prevent the expression of truncated lamin 
A and that even trace amounts of it may negatively interfere with structural and/or 
regulatory functions of lamin A/C eventually leading to the development of cardiomyopathy.  
  
Zusammenfassung 
Die Ergebnisse der vorgelegten Arbeit liefern neue Einblicke in die Assembly-Mechanismen 
der Kernlamina. Die Herstellung und Expression verschiedener Lamin-Mutanten in 
Kulturzellen ermöglichte es, den Einfluss bestimmter Lamin-Domänen auf Assembly-
Eigenschaften und  zelluläre Lokalisation der Proteine zu untersuchen. 
Lamin B2 mit teilweise oder komplett deletierter Kopfdomäne lokalisierte an der Kernhülle. 
Dennoch ließ die veränderte Kernmorphologie in diesen Zellen vermuten, dass die 
Kopfdomäne zwar für eine Lokalisation an der Kernhülle entbehrlich, jedoch für ein intaktes 
Lamina-Assembly notwending ist. Schwanz-deletierte Lamin B2 Mutanten hingegen wurden 
nicht in die Kernhülle eingebaut und verteilten sich sowohl über Zytoplasma als auch 
Nukleoplasma. Diese Schwanz-Domäne enthält also vermutlich jene Sequenzen, die wichtig 
sind für den Transport des Proteins an die Kernhülle. Die Schwanz-deletierten Mutanten 
beeinflussten jedoch nicht die Bildung der Lamina.  
Wir vermuteten, dass Mutationen der Phosphoakzeptor-Stellen vor und hinter der „Rod“-
Domäne von Serin nach Aspartat (die die mitosespezifischen Phospho-Serin-Gruppen 
imitieren) entweder die Integration der Mutanten in die Kernlamina verhindern oder zu deren 
Auflösung führen würden. Tatsächlich konnten diese Mutanten nicht in die Kernlamina 
eingebaut werden, und bildeten anstatt dessen intranukleäre Aggregate in U2OS Zellen aus. 
Erstaunlicherweise war diese Aggregatbildung unabhängig sowohl von der Position der 
Mutation als auch von der Anzahl mutierter Phosphoakzeptor-Stellen. 
Mit Lebendbeobachtung konnte gezeigt werden, dass diese Aggregate sehr dynamische 
Strukturen darstellen, die fusionierten und große Lamin-Territorien bildeten. 
Kotransfektionen dieser „Mitose“-Lamine B2 und B1 mit NLS-Vimentin ließen darauf 
schließen, dass die Aggregate im Interchromatin-Kompartiment abgelagert werden. Dennoch 
konnten wir keine Vermischung der transfizierten „Mitose“-Lamine mit NLS-Vimentin 
beobachten. Zwar sind die Mechanismen, die zur Aggregation und getrennten „Deponierung“ 
dieser Proteine führen, unbekannt, unsere Ergebnisse lassen aber auf die Existenz nukleärer 
„Protein-Prozessierungs-Zentren“ schließen. Diese könnten das lokale Entstehen zu hoher 
Proteindichten (aufgrund der starken Überexpression) verhindern, oder auch generell mit der 
Organisation und Verteilung von Kernproteinen in Beziehung stehen.  
Sowohl Wildtyp als auch mutierte Lamine wurden ebenfalls in embryonalen Stammzellen der 
Maus exprimiert. Die Fähigkeit zur Differenzierung in alle möglichen Zelltypen und ihr 
intakter diploider Karyotyp machen diese Zellen für zellbiologische Studien sehr wertvoll. Wie 
erwartet lokalisierten Wildtyp Lamin B1 und Lamin B2 an der Kernhülle, und der 
Stammzellcharakter der Zellen wurde durch ihre Expression nicht beeinflusst. Die Expression 
von Lamin B2 Deletionsmutanten in Mausstammzellen zeigte sehr ähnliche Ergebnisse wie in 
U2OS Zellen. Vermutlich liegen daher in Stammzellen wie in differenzierten Zellen die 
gleichen Prozessierungs- und Assembly-Mechanismen für die Kernlamina vor.  
  
Des Weiteren wurde eine neu charakterisierte Mutation des Lamin A/C Gens (pR321X) 
untersucht, die mit dilatierter Kardiomyopathie und Herzrhythmusstörungen einhergeht. 
Kulturzellen und Herzgewebe betroffener Patienten zeigten weder Veränderungen der 
Zellkerne, noch eine verminderte Expression des Wildtyp-Lamin A Proteins. In 
Übereinstimmung mit der Theorie des „Nonsens-mediated decay“ (NMD) wurde kein 
mutiertes Protein nachgewiesen. Dennoch konnte mit Hilfe von Proteasomen-Inhibitoren 
gezeigt werden, dass das mutierte Protein kurzzeitig angereichert wurde. Wir vermuten, dass 
der NMD nicht effizient genug ist, um die trunkierte Lamin A-Mutante vollständig abzubauen. 
Vermutlich sind auch Spuren dieser Mutante ausreichend, um strukturelle und/oder 
regulatorische Funktionen von Lamin A/C zu beeinträchtigen, was letztlich zur Ausbildung der 
Kardiomyopathie führt. 
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  Introduction 
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1 Introduction 
1.1 The nucleus 
The cell nucleus was first described in the 17th century by A. van Leeuwenhoek. In 
1831 R. Brown made the first detailed morphological description of the nucleus, and 
the “cell doctrine” of Matthias J. Schleiden und Theodor Schwann in 1839 claiming 
that all tissues are aggregates of individual cells marked the beginning of cell biology 
(described in Franke, 1988). Since these early days a lot more is known about the 
composition and the structure of the nucleus, but understanding the principles of the 
functional organization is still one of the major goals in cell biology. 
The eukaryotic nucleus is a complex organelle that contains the chromosomes and is 
the site of DNA replication, RNA transcription and processing, and ribosome 
assembly. It is about 10 µm in diameter and is surrounded by a double membrane 
layer punctured in intervals by nuclear pore complexes (NPCs). Many activities are 
concentrated in subnuclear foci called nuclear bodies. In contrast to the cytoplasmic 
compartments the nuclear compartments are not surrounded by membranes and are 
usually characterized by specific antigens that are generally in rapid exchange with 
non-bound species. The most prominent nuclear compartment is the nucleolus. It is 
the site of RNA polymerase I-mediated rDNA transcription and ribosome subunit 
assembly. Other nuclear substructures include nuclear speckles, Cajal bodies, and 
PML bodies (Lamond & Sleeman, 2003; Spector, 2003). 
The nucleus contains the chromosomes, consisting of highly condensed chromatin in 
mitosis and being organized into large scale domains called chromosome territories. 
Each chromosome territory occupies a predominantly distinct space in the 
nucleoplasm, even in interphase when they are in their most decondensed state. 
According to the level of compaction, one can distinguish between most condensed 
heterochromatin and less condensed euchromatin. In general, condensed 
heterochromatin domains tend to cluster preferentially at the nuclear periphery and 
around nucleoli, whereas the less condensed euchromatin is located within the 
nuclear interior (Lamond & Sleeman, 2003). 
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Figure 1: Proposed molecular interactions between components of the peripheral 
lamina, the nucleoskeleton and chromatin. INM, inner nuclear membrane; ONM, outer 
nuclear membrane; NPC, nuclear pore complex. Figure modified from Vlcek et al, 2001. 
 
The existence of a biochemically distinct nuclear compartment depends on the 
presence of a selective barrier, the nuclear envelope (NE), which separates nuclear 
and cytoplasmic cellular activities. The NE is a double membrane layer composed of 
two concentric bilayers, the outer nuclear membrane (ONM) which is continuous with 
the endoplasmatic reticulum (ER) and the inner nuclear membrane (INM). Outer and 
inner membranes are separated by a luminal space and are joined at sites, where 
nuclear pore complexes (NPCs) are inserted into the double membrane system. NPCs 
are large macromolecular assemblies that form aqueous gated channels across the 
NE and mediate the transport of macromolecules. The ONM has ribosomes attached 
to its outer surface and is biochemically and functionally similar to the ER. The INM, 
by contrast, is enriched in a distinctive set of membrane proteins. Associated is the 
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underlying lamina, consisting of lamin proteins, and chromatin (Aebi et al, 1986; 
Gerace & Burke, 1988). A proteomics analysis has suggested that as many as 80 
transmembrane proteins are localized to the INM in mammalian interphase cells 
(Schirmer et al, 2003). To date, only few of these proteins are characterized in detail. 
The lamina associated polypeptide (LAP) 2 family members, emerin and MAN1 
belong to a family of proteins that is defined by the presence of a so-called LEM 
domain. The LEM domain is exposed to the nucleoplasm and interacts with BAF 
(barrier-to-autointegration-factor), an abundant chromatin-associated protein 
(Shumaker et al, 2001). In this way, BAF might function as a link between certain 
INM proteins and chromatin. In addition, emerin, LAP1 and LAP2 family members 
and lamin B receptor (Holbrook et al) also interact with lamins. 
Metazoans contain another NE structural element called the nuclear lamina. In 
mammalian cells, this appears as a thin protein meshwork underlying the INM 
(Fawcett, 1966). The most prominent proteins in the nuclear lamina are lamins and 
associated proteins (Aaronson & Blobel, 1975; Gerace et al, 1978). Currently there is 
no molecular proof of a nuclear lamina outside the metazoa (Erber et al, 1999). The 
nuclear lamins are largely resistant to extraction, when cells are treated with high 
concentrations of non-ionic detergents and ionic strength (Aebi et al, 1986; Gerace & 
Burke, 1988; Goldman et al, 1986). Electron microscopic images of cells extracted in 
this way show an electron dense layer at the nuclear periphery which is in close 
association with the NPCs (Schneider et al, 1995).  
 
Figure 2: Field emission scanning electron micrographs showing lamina organization 
in Xenopus oocyte germinal vesicle. Manually isolated oocyte germinal vesicle envelopes 
were spread on silicon chips and either extracted with Triton X-100 (A) or fixed directly (B). Figure 
adapted from Broers et al, 2006. 
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It is still little known about the higher order structure of lamins in situ. In Xenopus 
oocytes and Necturus, both amphibian species, the lamina was shown to consist of a 
near-tetragonal meshwork of 10-nm-diameter lamin filaments (Aebi et al, 1986; 
Akey, 1989; Stuurman et al, 1998). These filaments attach directly to the NPCs, most 
likely to the spoke ring complex of nuclear pores (Aaronson & Blobel, 1975; Dwyer & 
Blobel, 1976; Goldberg & Allen, 1996; Scheer et al, 1976). Although the appearance 
of lamin filaments in other cell types is similar, a near-tetragonal meshwork of lamin 
filaments has not been visualized in other cells than the above mentioned (Goldberg 
et al, 1995).  
 
1.2 Lamins 
Nuclear lamins were initially identified as the major components of the nuclear 
lamina. In lesser amounts, lamins are also located throughout the nucleoplasm 
(Bridger et al, 1993; Goldman et al, 1992; Moir et al, 1994; Sasseville & Raymond, 
1995). Sequencing of lamin cDNA clones from different species revealed that nuclear 
lamins belong to the intermediate filament (Lenz-Bohme et al) protein family 
(McKeon et al, 1986). Lamins have been identified in numerous eukaryotic species, 
including Hydra, Caenorhabditis elegans, Drosophila melanogaster, and all 
vertebrates (Erber et al, 1999). Analysis of the complete genome sequence of both, 
yeast and Arabidopsis has revealed that these species do not have nuclear lamins. 
This suggests that these proteins may have evolved in animal cells during the 
transition from a closed to an open mitosis (Cohen et al, 2001). The number and 
complexity of lamins has increased during metazoan evolution. While Caenorhabditis 
elegans has only one lamin gene and protein, vertebrates have three lamin genes 
(LMNA, LMNB1, LMNB2) encoding at least seven distinct isoforms (Cohen et al, 
2001). In humans the LMNA gene is localized on chromosome 1q21.2 (Wydner et al, 
1996) and encodes the A-type lamins. It gives rise to four splice variants, lamin A, 
AΔ10, C, and C2 (Fisher et al, 1986; Furukawa et al, 1994; Machiels et al, 1996; 
McKeon et al, 1986). Three B-type lamins have been reported in humans so far. 
Lamin B1 is the unique product of the LNMB1 gene located on chromosome 5q23.3 
(Lin & Worman, 1995). LMNB2, localized at chromosome 19p13.3, has two 
alternatively spliced products, lamin B2 and B3 (Biamonti et al, 1992; Furukawa & 
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Hotta, 1993). B-type lamins are constitutively expressed in somatic cells throughout 
development and all vertebrates express at least on B-type lamin. In contrast, lamins 
A, C, and AΔ10 are developmentally regulated and are expressed primarily in 
differentiated cells (Machiels et al, 1996; Rober et al, 1989). Expression of lamin C2 
and lamin B3 is restricted to male germ-line cells (Furukawa & Hotta, 1993; 
Furukawa et al, 1994). Expression of B-type lamins is essential for nuclear integrity, 
cell survival and normal development. In contrast to B-type lamins, A-type lamins are 
dispensable for development. Despite the differences in the expression pattern of A- 
and B-type lamins, lamin isoforms are classified based on biochemical and structural 
criteria. A-type lamins are characterized by a neutral isoelectric point, while B-type 
lamins are more acidic (Gerace & Burke, 1988; Nigg, 1989; Peter et al, 1989). During 
mitosis when the lamina transiently disassembles, A-type lamins are completely 
solubilized and dispersed, whereas B-type lamins remain associated with remnants of 
nuclear membranes (Stuurman et al, 1998). Analyses of lamin and cytoplasmic IF 
genomic sequences indicate that nuclear lamins are the progenitors of all IF, with 
cytoplasmic IF arising through gene duplication (Riemer et al, 2000). 
 
1.2.1 Functions of nuclear lamins 
Since its discovery, the nuclear lamina has been thought to play primarily a structural 
role, supporting the nuclear membranes and the NPCs. It has been shown that 
mouse cells lacking lamin B1 have severely abnormal nuclear morphology (Vergnes 
et al, 2004). Depletion of A-type lamins leads to abnormalities in nuclear architecture 
and mislocalization of integral membrane proteins of the inner nuclear membrane 
(Harborth et al, 2001; Muchir et al, 2003; Nikolova et al, 2004; Sullivan et al, 1999). 
Such cells also have increased nuclear deformability, decreased mechanical stiffness, 
and decreased viability when subjected to mechanical strain (Broers et al, 2004; 
Lammerding et al, 2004). The lamina also plays a role in the spatial arrangement of 
nuclear pore complexes in the nuclear envelope (Aaronson & Blobel, 1975; Dwyer & 
Blobel, 1976; Smythe et al, 2000). Nuclear lamins may also be involved in the 
biogenesis or maintenance of the nuclear envelope membranes, as overexpression of 
prenylated lamins in cells induces excessive nuclear membrane formation and growth 
(Prufert et al, 2004; Ralle et al, 2004). The complex interactions of lamins and lamin-
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binding proteins with whole chromatin, DNA, and histones suggest functions of these 
proteins in higher order chromatin organization by providing specific chromatin 
docking sites at the NE and by structurally organizing chromatin fibers in the 3-
dimensional nuclear space (Glass et al, 1993; Goldberg et al, 1999; Luderus et al, 
1992; Stierle et al, 2003; Taniura et al, 1995). However, there may be much more to 
lamins than just a scaffolding function. Since higher order chromatin organization is 
ultimately linked to control of gene expression, lamina proteins might also be 
involved in this process. In addition, lamins may directly influence transcription by 
interacting with transcription factors and/or chromatin remodeling complexes 
(Mattout-Drubezki & Gruenbaum, 2003). There is significant amount of evidence that 
lamins play a role in DNA replication. Nuclei assembled in vitro in Xenopus egg 
extracts lacking a functional lamina fail to replicate DNA (Ellis et al, 1997; Moir et al, 
2000; Newport et al, 1990; Spann et al, 1997). Lamins have also been implicated in 
DNA replication at the cellular level by the finding that DNA replication sites or 
replication foci co-localize with nuclear lamins (Kennedy et al, 2000; Moir et al, 
1994). However, the precise spatial coincidence between the intranuclear pool of 
lamins and DNA replication sites is a matter of debate (Barbie et al, 2004; Dimitrova 
& Berezney, 2002; Kennedy et al, 2000). Recent studies provided direct evidence for 
nuclear lamin involvement in RNA polymerase II (Pol II)-dependent transcription 
(Kumaran et al, 2002; Spann et al, 2002). Some studies have also implicated lamins 
in RNA splicing (Jagatheesan et al, 1999; Kumaran et al, 2002). However, recent 
evidence indicates that formation of nuclear splicing compartments is independent of 
lamins A and C (Vecerova et al, 2004). Since lamins or domains of lamins have not 
been studied in in vitro assays of DNA replication, DNA transcription, and RNA 
splicing, their roles in these processes may be indirect, resulting from secondary 
effects of the pleiotropic functions of lamins. Finally, there is strong evidence now 
that lamina proteins are also involved in apoptosis, since inhibition of lamin cleavage 
delays apoptosis (Rao et al, 1996; Ruchaud et al, 2002), and conversely, inhibition or 
downregulaton of lamin B triggers apoptosis (Harborth et al, 2001; Steen & Collas, 
2001). 
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1.2.2 Laminopathies 
Mutations in genes encoding the nuclear lamins and associated proteins cause a wide 
spectrum of diseases commonly designated laminopathies. These diseases comprise 
a group of heterogeneous genetic disorders that have been associated with 
mutations in LMNA and, most recently, LMNB1 and LMNB2. More than 230 different 
mutations in the lamin A/C gene alone have been associated with at least twelve 
different heritable disease phenotypes (Mattout et al, 2006). These include diseases 
affecting muscle tissues (autosomal and recessive Emery-Dreifuss muscular 
dystrophy (EDMD), autosomal dominant limb girdle muscular dystrophy and dilated 
cardiomyopathy, all of which include cardiac conduction defects), adipose tissues 
(autosomal dominant Dunnigan-type familial partial lipodystrophy), and axonal 
neurons (recessive Charcot-Marie-Tooth disorder type 2) (Capell & Collins, 2006; 
Worman & Courvalin, 2005). Recently, the premature aging diseases Hutchinson-
Gilford progeria syndrome (HGPS), atypical Werner’s syndrome and mandibuloacral 
dysplasia have also been linked to mutations in LMNA (Broers et al, 2006; Worman & 
Courvalin, 2005). 
 
Figure 3: Schematic representation of LMNA mutations identified in the various types 
of laminopathies. Dominant disorders due to heterozygous LMNA mutations are depicted on the 
top of the protein scheme, whereas recessive disorders due to homozygous mutations are 
presented below. Figure adapted from Broers et al, 2006. 
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Heritable disease-causing mutations, including missense and nonsense mutations, 
frameshifts and splice site mutations, are distributed over almost the entire LMNA 
gene (Figure 3). Different patients carrying a single mutation may suffer multiple 
laminopathies, and the phenotype of any given LMNA mutation can vary between 
individuals and between siblings (Mattout et al, 2006). However, despite the 
knowledge of both type and position of these gene defects, the cellular mechanisms 
underlying the development of the various disease phenotypes are still largely 
unknown. There are three, not mutually exclusive models that try to explain 
laminopathic diseases. The structural model suggests that mutations in lamina 
proteins cause defects in lamin assembly and lamina structure leading to nuclear 
fragility or loss of nuclear organization. The gene expression model suggests that 
lamin complexes are important control elements of gene expression such that their 
absence is fatal. Finally, the cell fate model suggests that their mutation is linked to 
early apoptosis or premature aging (Herrmann & Foisner, 2003).  
 
1.2.3 Structure of nuclear lamins 
Nuclear lamins are type V intermediate filaments. Analyses of lamin and cytoplasmic 
IF genomic sequences indicate that nuclear lamins are the progenitors of all IF, with 
cytoplasmic IF arising through gene duplication (Riemer et al, 2000).  
Similar to cytoplasmic IFs, lamins have a characteristic tripartite organization 
consisting of a short N-terminal head domain, a central α-helical rod domain and a 
long C-terminal globular tail domain (Figure 4). The rod domain comprises four 
coiled-coil forming domains (1A, 1B, 2A, 2B) separated by more or less flexible linker 
regions (L1, L12, and L2). The hydrophobic residues in the first and fourth position of 
a heptad in a α-helical subdomain drive the interaction between two lamin protein 
chains, to form a parallel, in register coiled-coil dimer, the basic structural unit of 
lamin assembly (Stuurman et al, 1998). The α-helical rod domain is flanked by highly 
conserved phosphoacceptor sites which are phosphorylated with the onset of mitosis 
and thereby causing morphological changes involving the disassembly of the lamina 
meshwork (Heald & McKeon, 1990; Peter et al, 1990). 
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Figure 4: Structural model of cytoplasmic and nuclear intermediate filament protein 
dimers (Herrmann et al, 2007). 
 
The non α-helical head and tail domains play an important role in lamin assembly 
(Moir et al, 1991). The C-terminal tail domain contains a nuclear localization 
sequence (NLS) which is necessary for nuclear import of lamins (Loewinger & 
McKeon, 1988). Mammalian lamins, except for lamin C and C2, possess at the very 
C-terminus a CAAX box motif. 
 
1.2.4 Lamin filament assembly 
Studies of nuclear lamin assembly in vitro have revealed interesting differences 
relative to cytoskeletal IFs. Lamins are obligate dimers, although it is still not clear 
whether lamins form homodimers or heterodimers (Gruenbaum et al, 2005). 
Dimerization occurs through in register parallel associations within the coiled coil 
domains of the central rod region (Aebi et al, 1986). At their next level of structural 
organization, lamin dimers associate longitudinally to form polar head to tail 
polymers. In a further step, lamin head to tail polymers associate laterally, probably 
in an antiparallel, approximately half-staggered fashion. However, at least in vitro 
these protofilaments are not stable over time and, instead, further associate laterally 
into large paracrystalline structures (Stuurman et al, 1998). These paracrystals do 
not exist in vivo under normal circumstances. Elimination of the head, and to a lesser 
extent, tail domains inhibits the formation of head-to-tail polymers (Heitlinger et al, 
1992).  
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1.2.5 Modifications of nuclear lamins 
The CAAX box motif (a cysteine (C), two aliphatic residues (AA), and any residue (X)) 
at the very C-terminus of lamins is the target for a sequence of posttranslational 
modifications. Initially, the cysteine is farnesylated followed by proteolytic cleavage 
of the last three amino acids (AAX). After this cleavage the cysteine undergoes 
methyl esterification (Moir et al, 1995). The farnesylated modification is important 
but not sufficient for targeting and anchoring the protein to the INM (Moir et al, 
1995). While B-type lamins remain farnesylated throughout their lifespan, prelamin A 
undergoes another maturation step in which the 15 C-terminal amino acids, including 
the farnesyl group, are cleaved off by the ZMPSTE24 zinc metalloproteinase 
(Corrigan et al, 2005; Weber et al, 1989). Therefore, B-type lamins are more tightly 
associated with membrane structures than A-type lamins in mitosis and interphase 
and are less stably incorporated into the lamina (Gerace & Burke, 1988; Izumi et al, 
2000). 
Lamins contain a great number of putative phosphorylation sites (serine/threonine). 
Highly conserved serine residues flanking the rod domain are phosphorylated with 
the onset of mitosis by a cdc2 kinase (Heald & McKeon, 1990; Nigg, 1992; Peter et 
al, 1990). This hyperphosphorylation leads to the depolymerization of the lamina in 
vivo concomitant with NE breakdown. In vitro studies showed that phosphorylation 
of lamin dimers inhibited the formation of higher order assemblies such as polar 
head-to-tail polymers (Nigg, 1992; Peter et al, 1991). These findings have led to the 
conclusion that lamina disassembly follows a similar principle in vivo and that the 
formation of head-to-tail polymers is influenced by the degree of phosphorylation at 
sites flanking the rod domain. Mitotic A-type lamins solubilize and are dispersed 
throughout the cytoplasm, while B-type lamins remain associated with nuclear 
membrane structures due to their C-terminal farnesyl modification (Nigg et al, 1992). 
Following mitosis, lamins are dephosphorylated by phosphatase PP1 (Steen et al, 
2000) and bind on the periphery of decondensing chromosomes. B-type lamins are 
suggested to be incorporated into the reforming NE in earlier stages whereas A-type 
lamins are incorporated only after the nuclear membranes and pores are formed.  
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1.2.6 Lamins in the nuclear interior 
Lamins were traditionally regarded as the major building blocks of the peripheral 
nuclear lamina underneath the inner nuclear membrane. After many years of debate, 
the idea that lamins exist also in the nuclear interior is mostly accepted (Dechat et al, 
2000; Moir et al, 2000). Since the nuclear membrane forms extensive tubular 
invaginations extending into the nucleoplasm (Fricker et al, 1997) it is likely that at 
least some of the intranuclear foci observed are still in direct contact with the nuclear 
envelope. Two different manifestations of intranuclear lamins have been reported: 
1.) intranuclear spots (Bridger et al, 1993; Goldman et al, 1992; Moir et al, 1994) 
that contain either A- or B-type lamins; and 2.) lamins distributed in a diffuse fashion 
throughout the nucleus (Hozak et al, 1995). It remains unclear whether intranuclear 
lamins form filaments as detected in some electron microscopic preparations (Hozak 
et al, 1995). However, free vimentin-type 10-nm filaments within the nucleus, as 
observed upon ectopic expression of NLS-modified vimentin (Goldman et al, 1992; 
Herrmann et al, 1993), have not been described for intranuclear lamins (Herrmann & 
Foisner, 2003). It is also unclear whether lamins in the nucleoplasm represent 
transient structures during lamina assembly (Bridger et al, 1993; Goldman et al, 
1992) mediating their posttranslational processing, or whether they fulfill specific 
functions in the nucleus. Nucleoplasmic lamin A/C has been shown to interact with 
lamina-associated polypeptide 2α (LAP2α), a LAP2 isoform exclusively located 
throughout the nucleoplasm (Dechat et al, 2000; Markiewicz et al, 2002). LAP2α-
lamin A/C complexes have further been shown to interact with the tumor suppressor 
retinoblastoma protein pRB (Markiewicz et al, 2002), implicating a function in 
transcriptional control. As lamins are often associated with nuclear bodies 
(Jagatheesan et al, 1999; Moir et al, 1994) they may represent nucleoplasmic 
functional units involved in DNA replication, transcription, chromatin organization and 
gene expression (Moir et al, 2000; Spann et al, 2002).  
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1.3 Aim of the thesis  
The aim of this thesis was to investigate basic steps in the mechanism of lamin in 
vivo assembly and the “cross-talk” of lamin assembly processes with nuclear 
morphology. For this reason, we wanted to follow a dominant negative type 
approach by use of different lamin mutants. 
In the first part of the project, the impact of distinct domains of the lamin protein on 
lamin assembly was analyzed. Human lamin B2 is the least studied lamin and 
therefore, several human lamin B2 mutants fused to YFP were generated carrying 
head and/or tail deletions. In a next step, we generated lamin B1 and lamin B2 
mutants, in place of the highly conserved mitotic serine residues exhibiting aspartic 
acids. All mutants should be expressed in different cancer cell lines and their cellular 
localization and influence on the lamina and on inner nuclear membrane proteins 
should be analyzed by confocal microscopy. In addition, we wanted to analyze all 
mutants biochemically with regard to their solubility properties. Beside the use of 
different cancer cell lines, we aimed to analyze wild type lamins and lamin mutants 
both fused to YFP in mouse embryonic stem (ES) cells. Their ability to differentiate 
into all specialized cell types found in the adult mouse and the exhibition and 
maintenance of a normal diploid complement we of chromosomes make them a 
valuable tool for cell biological studies. Therefore, we wanted to establish ES cell 
culture in our laboratory and establish the conditions for transfection of these cells 
and further processing for microscopy.  
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2 Material 
2.1 Biological material 
2.1.1 Bacterial strains 
E. coli TG-1, sure, and XL10 gold (Stratagene, Germany) strains were used for 
amplification and preparation of plasmid DNA.  
 
2.1.2 Cultured cell lines 
Table 1: Cell lines used in this thesis. 
 
2.1.3 Stably transfected culture cell lines 
Table 2: Properties of the used stably transfected cell lines. 
 
 
 
 
 
designation. ATCC no. organism/tissue characteristics 
HeLa ACC 57 human cervix 
carcinoma 
adherent monolayer 
SW13-F8 CCL-105 human primary 
small cell carcinoma 
adrenal gland; cortex 
adherent monolayer 
U2OS HTB-96 human osteosarcoma adherent monolayer 
HM1 ES Magin et al., 
1992 
mouse embryonic stem 
cells 
adherent 
designation origin stably transfected expression plasmid 
eukaryotic 
resistance
U2OS H2A-CFP U2OS cells human histone H2A-CFP Neomycin 
U2OS LB2 S407D-YFP U2OS cells human lamin B2 S407D-pEYFP-C1 Neomycin 
U2OS LB2 S37+407D-YFP U2OS cells human lamin B2 S37+407D-pEYFP-C1 Neomycin 
ES LB2-YFP HM1 ES 
cells 
human lamin B2-pEYFP-C1 Neomycin 
ES LB1-YFP HM1 ES 
cells 
human lamin B1-pEYFP-C1 Neomycin 
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2.2 Expression vectors 
Table 3: Expression vectors used for transfection of cell cultures. 
 
2.3 Expression plasmids 
Table 4: Origin of the used expression constructs. 
plasmid vector size in bp resistance reference 
  prokaryotic eukaryotic  
pEGFP-C1 4700 kanamycin neomycin Clontech, Germany 
pEYFP-C1 4700 kanamycin neomycin Clontech, Germany 
pECFP-C1 4700 kanamycin neomycin Clontech, Germany 
mCherry-C1 4700 kanamycin neomycin Tsien et al., 2004 
construct reference 
Human Lamin B2-pEYFP-C1 this study 
Human Lamin B2 Δ32head-pEYFP-C1 this study 
Human Lamin B2 headless-pEYFP-C1 this study 
Human Lamin B2 tailless-pEYFP-C1 this study 
Human Lamin B2 Δ32head/tailless-pEYFP-C1 this study 
Human Lamin B2 rod-pEYFP-C1 this study 
Human Lamin B2 S37D-pEYFP-C1 this study 
Human Lamin B2 S405D-pEYFP-C1 this study 
Human Lamin B2 S407D-pEYFP-C1/-pEGFP-C1/-mCherry this study 
Human Lamin B2 S37+405D-pEYFP-C1 this study 
Human Lamin B2 S37+407D-pEYFP-C1 this study 
Human Lamin B2 S405+407D-pEYFP-C1 this study 
Human Lamin B2 S37+405+407D-pEYFP-C1 this study 
Human Lamin B1-pEYFP-C1 this study 
Human Lamin B1 S23D-pEYFP-C1 this study 
Human Lamin B1 S391D-pEYFP-C1 this study 
Human Lamin B1 S393D- pEYFP-C1/-pEGFP-C1/-mCherry this study 
Human PCNA-CFP (Leonhardt et al, 2000) 
Human histone H2A-CFP T. A. Knoch 
Human lamin A p.R321X-pEGFP-C1 this study 
Xenopus laevis NLS-vimentin-pEGFP (Reichenzeller et al, 2000) 
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2.4 Antibodies 
2.4.1 Primary antibodies 
Table 5: Origin, properties and dilution of the used primary antibodies. 
 
2.4.2 Secondary antibodies 
Species specific antibodies conjugated with Alexa 488, Alexa 568 (Molecular Probes, 
Netherlands) or Cy5 (Dianova, Germany) were used for immunofluorescence.  
Membrane bound antigen-antibody complexes were detected by use of horseradish 
peroxidase coupled antibodies raised against mouse, rabbit or guinea pig 
immunoglobulins (Dianova, Germany).  
 
2.5 Size markers 
2.5.1 DNA size markers 
As DNA size markers EcoRI and HindIII digested λ-DNA (λ/E/H marker) or HinfI 
digested pBluescribe DNA (BsHinf marker) were used. Digestion yields the following 
discrete fragments (in base pairs): 
 
λ/E/H marker: 24.700, 5148, 4973, 4268, 3480, 2027, 1904, 1584, 1375, 
947, 831, 564, 125 
 
BsHinf marker 1400, 517, 396, 356, 247, 75 
antibody antigen type origin IF WB reference 
X223 lamin B2 monoclonal mouse undiluted 1:5 (Hoger et al, 
1991) 
X167 lamin A monoclonal mouse undiluted 1:5 (Hoger et al, 
1991) 
LA-Z1 lamin A monoclonal mouse undiluted 1:5 (Geiger et al, 
2008) 
5-1-3 LBR monoclonal rabbit undiluted - Epitomics INC 
EM-N-term Emerin polyclonal guinea pig 1:300 - (Dreger et al, 
2002) 
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2.5.2 Protein size markers 
As protein size marker the Broad Range P7702L marker (New England Biolabs, 
Germany) was used. It comprises the following fragments (in kDa): 
 
Broad Range P7702L marker 212, 158, 116, 97.2, 66.4, 55.6, 42.7, 34.6, 27, 20, 
14.3, 6.5, 3.4, 2.3 
 
2.6 DNA oligonucleotides 
All oligonucleotides used for PCR amplification, cloning, and DNA sequencing were 
synthesized by Dr. Wolfgang Weinig (DKFZ, Heidelberg). Primers used for 
mutagenesis were bought in HPLC grade from MWG Biotech (Germany).  
 
2.7 Chemicals and enzymes 
The used chemicals and reagents were purchased in analytical quality from the 
following companies: Invitrogen (Germany), Fluka (Germany), Merck (Germany), 
Pharmacia (Germany), Roche (Germany), Roth (Germany), Serva (Germany), Sigma 
(Germany), Qiagen (Germany). 
Enzymes were purchased from Roche (Germany), Stratagene (Germany), and New 
England Biolabs (Germany). 
 
2.8 Cell culture material 
1-thioglycerol Sigma-Aldrich, Germany 
BMP-2 (bone morphogenic protein ) kindly provided by T. Magin, Bonn 
Bovine albumin fraction V Invitrogen, Germany 
DMEM (High Glucose) Invitrogen, Germany 
DMEM-F12 Invitrogen, Germany 
DMSO Sigma-Aldrich, Germany 
Epoxomicin Sigma-Aldrich, Germany 
Fetal calf serum Biochrom, Germany 
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Gelatine swine skin type I Sigma-Aldrich, Germany 
Geniticin Sigma-Aldrich, Germany 
Insulin, human recombinant, zinc Invitrogen, Germany 
L-glutamine Invitrogen, Germany 
LIF (leukemia inhibitory factor) kindly provided by T. Magin, Bonn 
Neurobasal medium Invitrogen, Germany 
Penicillin and Streptomycin Invitrogen, Germany 
Progesteron Sigma-Aldrich, Germany 
Putrescin Sigma-Aldrich, Germany 
Sodium selenite Sigma-Aldrich, Germany 
Supplement B27 Invitrogen, Germany 
Transferrin, bovine (APO form) Invitrogen, Germany 
Trypsin inhibitor Sigma-Aldrich, Germany 
Trypsin solution Invitrogen, Germany 
 
2.9 Media and solutions 
 
 
 
 
 
LB-medium (pH 7.2) 1% Bacto tryptone (w/v) 
 0.5% yeast extract (w/v) 
 86 mM NaCl 
 10 mM MgSO4 
LB-media with antibiotics Appropriate antibiotics were added after 
autoclaving of LB-medium. The 
concentration of ampicillin was 100 µg/ml 
and of kanamycin 50 µg/ml. 
LB-agarplates with antibiotics 15 g agar was added to 1000 ml LB-
medium and autoclaved. Antibiotics were 
added to the cooled, autoclaved medium. 
TAE (pH 8.0) 40 mM Tris/HCl 
 0.12% acetic acid 
 1 mM EDTA 
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6x DNA loading dye 200 mM EDTA 
 100 mM Tris/HCl (pH 7.5) 
 0.01% bromophenol blue (w/v) 
 0.01% xylencyanol 
 30% ficoll (w/v) 
PBS (pH 7.4) 2.7 mM KCl 
 1.7 mM KH2PO4 
 137 mM NaCl 
 10 mM Na2HPO4 
TE 10 mM Tris/HCl (pH 7.5) 
 1 mM EDTA 
Laemmli electrophoresis buffer 25 mM Tris/HCl 
 192 mM glycine 
 0.1% SDS (w/v) 
Lower Tris 1.5 M  Tris/HCl (pH 8.8) 
 0.4% SDS (w/v) 
Upper Tris 0.5 M  Tris/HCl (pH 6.8) 
 0.4% SDS (w/v) 
3x Laemmli sample buffer 30% glycerine 
 0.2% bromophenol blue (w/v) 
 9% SDS (w/v) 
 187.5 mM Tris/HCl 
 150 mM DTT 
Coomassie stain 40% isopropanol 
 7% acetic acid 
 0.2% Coomassie Brilliant Blue R-50 
Coomassie destain 20% isopropanol 
 7.5% acetic acid 
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2.10 Kits 
 
2.11 Instruments 
 
Borate transfer buffer (pH 8.8) 20 mM boric acid 
 1 mM Na2-EDTA 
 4 mM DTT 
TBST (pH 8.0) 10 mM Tris/HCl 
 150 mM NaCl 
 0.05% Tween 20 
ECL Kit PerkinElmer Life Sciences, USA 
FuGene6  Transfection Reagent Roche, Germany 
Lipofectamine 2000 Transfection Reagent Invitrogen, Germany 
Qiaquick PCR-Purification Kit Qiagen, Germany 
QIAprep spin Miniprep Kit Qiagen, Germany 
Qiaex Agarose Gel Extraction Kit Qiagen, Germany 
Qiagen Plasmid Maxi Kit Qiagen, Germany 
QuikChange II XL Site-Directed Mutagenesis Kit Stratagene, Germany 
Agarose gel electrophoresis apparatus Cti-GmbH, Germany 
Centrifuges Heraeus, Germany 
 Beckmann, Germany 
CO2 incubator Thermo Life Sciences, Germany 
Fluorescence microscope Zeiss, Germany 
Gel documentation system DNR Bio-imaging systems 
Gel electrophoresis power supply Biotech Fischer, Germany 
Laser scanning microscope Leica TCS SP2 Leica Microsystems, Mannheim 
NanoDrop spectrophotometer NanoDrop Technologies, USA 
PCR cycler MJ Research, Biozym, Germany 
pH-meter Schott, Germany 
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Refrigerated centrifuge Eppendorf, Germany 
SDS-PAGE gel apparatus Cti-GmbH, Germany 
Vortex mixer Neolab Migge, Germany 
Water baths Julabo, Germany 
Western blot apparatus Bio Rad, Germany 
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3 Methods 
3.1 DNA techniques 
3.1.1 Preparation of competent bacteria 
The treatment of E.coli cells with calcium chloride solution leads to an increased 
uptake of DNA from the solution into the bacteria.  
An over night culture (5 ml) of E.coli was diluted 1:100 to a final volume of 400 ml 
LB-medium and grown in a shaker at 37°C to an optical density of OD600 = 0.5-0.6. 
Subsequently, the culture was centrifuged for 5 minutes at 0°C at 5000 rpm 
(Beckmann J2-HS-centrifuge, rotor JA-14). The cell pellet was resuspended in 100 ml 
ice cold sterile 0.1 M CaCl2 solution and incubated on ice for 30 minutes. Cells were 
again centrifuged as described above. The pellet was resuspended in 2 ml freezing 
solution (0.1 M CaCl2, 15% glycerine (v/v)) and stored at -80°C. 
 
3.1.2 Transformation of competent bacteria 
The term transformation describes the uptake of plasmid DNA into competent 
bacteria using a heat shock. 
Competent E. coli cells were thawed on ice. 4-10 ng plasmid-DNA was added, 
followed by incubation for 20-30 minutes on ice. Depending on the bacterial strain 
heat shock temperature was adapted (42°C for XL gold and 37°C for TG-1 and sure). 
The heat shock duration was 3 minutes. Cells were immediately cooled on ice for 1 
minute. After addition of 400 µl LB-medium, cells were incubated at 37°C for 60 
minutes. According to the antibiotic resistance of the transformed plasmid DNA, cells 
were plated on agar plates with the respective selection marker and incubated over 
night at 37°C. 
 
3.1.3 Isolation of plasmid DNA ( ̒Miniprep ̓, ̒Maxiprep ̓) 
E. coli containing the plasmid of interest were grown on agar plates. Colonies were 
picked from the plates and grown for minipreps in 2 ml LB-medium containing the 
appropriate antibiotic in a shaking incubator at 37°C over night. For maxipreps a 5 
  Methods 
22 
ml preculture in LB-medium was grown for 6 hours and transferred to an overnight 
culture (100 ml for low-copy and 500 ml for high-copy plasmids). Isolation of plasmid 
DNA was performed according to the manufacturers protocol (QIAprep Spin Miniprep 
Kit and Qiagen Plasmid Maxi Kit; Qiagen, Germany).  
 
3.1.4 Agarose gel electrophoresis 
DNA fragments can be separated in an electric field according to their size by 
agarose gel electrophoresis. The used concentration of the agarose is dependent on 
the size of the DNA fragments. 
 
Table 6: Agarose concentration and separation range in kb for DNA fragments 
 
 
The agarose was melted by boiling in 1x TAE buffer. After cooling to 60°C, ethidium 
bromide was added to a final concentration of 1 µg/ml. The solution was poured into 
a horizontal casting tray and was allowed to harden. For electrophoresis, the gel was 
placed in a gel chamber and was covered with 1x TAE buffer. The samples mixed 
with 6x DNA loading buffer and a DNA size marker (see  2.5.1) were loaded onto the 
gel. Electrophoresis was run at 70-90 V. After the run, the separated DNA bands 
were visualized with a transilluminator at 280 nm.  
 
3.1.5 Determination of DNA concentration 
The concentration of DNA was measured in a spectrophotometer (NanoDrop 
Technologies, USA). The absorbance of the nucleic acid solution was measured with 
a wavelength of λ = 260 nm.  
 
agarose concentration separation range in kilo bases (kb) 
0.5% 1-30 
1% 0.5-10 
1.5% 0.2-3 
2% 0.05-2 
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3.1.6 Restriction digestion 
3.1.6.1 Analytical restriction digestion 
Analytical restriction digestion was used to check for the correct orientation and 
length of the inserted DNA fragment into the plasmid vector. 
1-2 µg of plasmid DNA was digested with 5 units of restriction enzyme. Buffer was 
used as recommended by the manufacturer. Digests were normally incubated for 1 
hour at 37°C. The DNA fragments were analyzed by agarose gel electrophoresis (see 
 3.1.4).  
 
3.1.6.2 Preparative restriction digestion 
The preparative restriction digestion was used to isolate specific DNA fragments. 2-4 
µg of plasmid DNA was digested with 5-10 units of restriction enzyme in the 
appropriate buffer for 1-2 hours at 37°C. The DNA was separated by agarose gel 
electrophoresis (see  3.1.4) on a low melting agarose gel. The DNA bands were cut 
out with a disposable scalpel as precise as possible on a transilluminator at 366 nm 
and put into a reaction tube. Gel slices were washed for 5 minutes in 500 µl band 
washing buffer. After removal of the washing buffer, the reaction tube was incubated 
for 3-5 minutes at 70°C. The melted gel slice was directly used for ligation or was 
stored at -20°C until use. Alternatively, DNA was extracted from the gel with a gel 
extraction kit (Qiaex Agarose Gel Extraction Kit; Qiagen, Hilden) according to the 
manufacturer’s instruction. 
 
3.1.6.3 Partial restriction digestion 
4-5 µg of plasmid DNA was digested with 5-10 units of the single cutting enzyme at 
37°C in a final volume of 40 µl. After 1-2 hours, 5-10 units of the multi cutting 
enzyme were added and the final volume was adjusted to 85 µl. Digests were 
incubated at 37°C. 10 µl samples were taken after 2, 5, 10, 15, 20, 25, 30, and 40 
minutes and mixed with 2 µl of 6x DNA loading buffer with 100 mM EDTA and kept 
on ice. Subsequently, 2 µl of each sample were subjected to agarose gel 
electrophoresis (see  3.1.4). Samples containing the desired DNA fragment were 
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pooled and loaded onto a low melting agarose gel. The DNA band of interest was cut 
out with a scalpel and processed as described in section  3.1.6.2. 
 
3.1.7 PCR 
In order to amplify a specific DNA target sequence, a forward and reverse primer 
were designed. They contained ~20 bases complementary to the target sequence 
and recognition sites for restriction enzymes at the 5 ̓ and 3̓ end. The target 
sequences were amplified with Pfu DNA polymerase (Stratagene, Germany).  
A standard PRC reaction contained: 5 ng template DNA, 170 ng of each primer, 5 µl 
dNTP mix, 5 µl 10x polymerase buffer, 1 µl DNA polymerase and was adjusted with 
ddH2O to a final volume of 50 µl. In some cases 3, 6, or 9% DMSO were added to 
the reaction in order to lower the DNA melting temperature.  
The following PCR cycling program was used: 
 
 
The annealing temperature was modified according to the used primer pairs. PCR 
products were then analyzed on a 1% agarose gel. 
 
3.1.8 Purification of PCR products 
The PCR products were purified from primers and nucleotides before restriction 
digestion. Purification was performed according to the protocol of a PCR purification 
kit (Qiaquick PCR Purification Kit; Qiagen, Hilden).The purified fragments were finally 
dissolved in 30 µl TE buffer. 
 
1 cycle initial denaturation 3 minutes 94°C 
35 cycles denaturation 20 seconds 92°C 
 annealing 30 seconds 58°C 
 extension 1 minute 72°C 
1 cycle final extension 10 minutes 72°C 
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3.1.9 Site-directed Mutagenesis 
In order to replace single amino acids the QuikChange II XL Site-Directed 
Mutagenesis kit (Stratagene, Germany) was used according to the manufacturer’s 
instructions. The site-directed mutagenesis method is performed using a high-fidelity 
DNA polymerase for mutagenic primer-directed replication of both plasmid strands. 
The basic procedure utilizes a supercoiled double-stranded DNA vector with an insert 
of interest and two synthetic oligonucleotide primers, both containing the desired 
mutation. The primers used were between 25 and 40 bases in length and were 
designed so that they annealed to the same sequence on opposite strands of the 
plasmid. Both mutagenic primers contained the desired mutation in the middle of the 
primer flanked by sequences complementary to the template sequence.  
The primers are extended during temperature cycling by the DNA polymerase, 
without primer displacement. Extension of the primers generates a mutated plasmid 
containing staggered nicks. Following temperature cycling, the product is treated 
with DpnI endonuclease, which is specific for methylated and hemimethylated DNA 
and is used to digest the parental DNA template and to select for mutation-
containing synthesized DNA. The nicked vector DNA incorporating the desired 
mutation is then transformed into E. coli XL10 Gold cells. 
 
3.1.10 Removal of 5 ̓-phosphate residues from DNA fragments 
In order to prevent re-ligation of a linearized vector, the phosphate groups which 
deliver the reactive phosphor required for the sugar-phosphate bonds of the DNA, 
were removed by an alkaline phosphatase (Shrimp alkaline phosphatase, SAP). 
The digested vector DNA was dephosphorylated for 1 hour with 1 unit SAP at 37°C 
and subsequently inactivated for 15 minutes at 70°C. 
 
3.1.11 Phosphorylation and annealing of DNA oligomers 
In order to insert DNA oligomers into plasmids by ligation, the complementary 
oligomers have to be phosphorylated at the 5 ̓ end and have to be annealed.  
For phosphorylation, 0.5 nM oligomers were incubated in 2 µl 10x polynucleotide 
kinase buffer in a final volume of 18 µl for 10 minutes at 70°C. After denaturation,  
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1 µl 10 mM ATP and 1 µl (=10 units) polynucleotide kinase were added and 
incubated for 30 minutes at 37°C. The reaction was stopped by incubation for 10 
minutes at 70°C. 100 ng of each oligomer were used for the annealing reaction and 
incubated in 50 µl TE with 50 mM NaCl for 10 minutes at 70°C and for 30 minutes at 
37°C. For ligation, 4, 10, and 20 ng were used. 
 
3.1.12 Ligation 
For ligation and the following transformation into E. coli cells, the ratio of insert to 
vector was ranging from 5:1 to 10:1. Either purified PCR products or DNA fragments 
isolated from low melting agarose gels were ligated. The reaction was carried out in 
a final volume of 20-30 µl by addition of 10x ligase buffer and 1 µl (=1 unit) T4 DNA 
ligase and was either incubated for 2 hours at 16-18°C or over night at 4°C.  
 
3.1.13 DNA sequencing 
All cloned expression plasmids were sequenced by Andreas Hunziker (DKFZ, 
Heidelberg) to verify the DNA sequence.  
 
3.2 Generation of expression plasmids 
The full-length human lamin B2 cDNA clone BC006551 (NCBI data bank) in pOTB 
was obtained from the RZPD (Germany). The full-length human lamin B1 cDNA in 
pBluescript was provided by E. Tan (The Scripps Research Institute, La Jolla, USA).  
 
3.2.1 Human lamin B2 
The coding sequence of the human lamin B2 cDNA in pOTB was partially amplified by 
PCR. A fragment encoding amino acid 1-77 was amplified using a forward primer 
(SG96: 5’-GAGAGATCCGGAATGAGCCCGCCGAGCCCG-3’) inserting a BspEI restriction 
site and a reverse primer (SG97: 5’-CTTCTCTGAGATCTTGAGCAGGAGCCGGTCG-3’). 
The PCR product was digested with BspEI/BglII and was inserted into the multiple 
cloning site of pEYFP-C1. Human lamin B2 headless cDNA in pEYFP-C1 (see below) 
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was digested with BglII/EcoRI and was ligated into cloned lamin B2 [1-77] in pEYFP-
C1 digested with the same enzymes. The resulting cDNA construct was validated by 
sequencing. 
 
3.2.2 Human lamin B2 deletion mutants 
For generation of human lamin B2 deletion mutants the coding sequence of the 
human lamin B2 cDNA in pOTB was partially amplified by PCR and cloned comprising 
the following fragments:  
 
a) LB2[33-309]  
Amplified with a forward primer (SG8: 5’-GAGAGAGGATCCATGGCCACGCCGCTGTCG 
CCCACG-3’) introducing a start codon and a NcoI restriction site and a reverse primer 
(SG4: 5’-CTCCCCGGCCATGGCCTCCTCCAGCTCCCGAATGC-3’). The PCR product was 
digested with NcoI and ligated into the multiple cloning site of a modified pBluescript 
cut with the same enzyme. The construct was validated by sequencing. 
 
b) LB2[46-309]  
Amplified with a forward primer (SG3: 5’-GAGAGAGGATCCATGGAGAAGGAGGAGCTGC 
GCGAGC-3’) introducing a start codon and a NcoI restriction site and a reverse 
primer (SG4: 5’-CTCCCCGGCCATGGCCTCCTCCAGCTCCCGAATGC-3’). The PCR 
product was digested with NcoI and ligated into the multiple cloning site of a 
modified pBluescript cut with the same enzyme. The construct was validated by 
sequencing. 
 
c) LB2[310-402]  
Amplified with a forward primer (SG5: 5’-CGGGAGCTGGAGGACGCCATGGCCGGGG 
AGC-3’) and a reverse primer (SG6: 5’-GAATTCTTACAGCCTCTCCTCCTCGCC-3’) 
introducing a stop codon and a EcoRI restriction site. The PCR product was digested 
with NcoI/EcoRI and ligated into the multiple cloning site of a modified pBluescript 
cut with the same enzymes. The construct was validated by sequencing. 
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d) LB2[310-620]  
Amplified with a forward primer (SG5: 5’-CGGGAGCTGGAGGACGCCATGGCCGGGG 
AGC-3’) and a reverse primer (SG7: 5’-GAGAGAGAATTCTTACATCACGTAGCAGCCTC 
TTG-3’) introducing a EcoRI restriction site. The PCR product was digested with 
NcoI/EcoRI and ligated into the multiple cloning site of a modified pBluescript cut 
with the same enzymes. The construct was validated by sequencing. 
 
3.2.2.1 Human lamin B2 Δ32head 
Cloned LB2[33-309] cDNA in pBluescript was digested with NcoI and ligated into 
LB2[310-620] in pBluescript cut with the same enzymes. The resulting LB2 Δ32head 
cDNA in pBluescript was then cut out by partial restriction digestion with BspEI/EcoRI 
and was ligated into the multiple cloning site of pEYFP-C1. The construct was 
validated by sequencing.  
 
3.2.2.2 Human lamin B2 headless 
Cloned LB2[46-309] cDNA in pBluescript was digested with NcoI and ligated into 
LB2[310-620] in pBluescript cut with the same enzymes. The resulting LB2 headless 
cDNA in pBluescript was then cut out by partial restriction digestion with BspEI/EcoRI 
and was ligated into the multiple cloning site of pEYFP-C1. The construct was 
validated by sequencing.  
 
3.2.2.3 Human lamin B2 tailless 
Cloned LB2 rod cDNA in pEYFP-C1 (see below) was digested with BglII/EcoRI and 
ligated into full-length lamin B2 cDNA in pEYFP-C1 cut with the same enzymes. The 
construct was validated by sequencing.  
 
3.2.2.4 Human lamin B2 Δ32head/tailless 
Cloned LB2[33-309] cDNA in pBluescript was digested with NcoI and ligated into 
LB2[310-402] in pBluescript cut with the same enzymes. The resulting LB2 
Δ32head/tailless cDNA in pBluescript was then cut out by partial restriction digestion 
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with BspEI/EcoRI and was ligated into the multiple cloning site of pEYFP-C1. The 
construct was validated by sequencing.  
 
3.2.2.5 Human lamin B2 rod 
Cloned LB2[46-309] cDNA in pBluescript was digested with NcoI and ligated into 
LB2[310-402] in pBluescript cut with the same enzymes. The resulting LB2 rod cDNA 
in pBluescript was then cut out by partial restriction digestion with BspEI/EcoRI and 
was ligated into the multiple cloning site of pEYFP-C1. The construct was validated 
by sequencing.  
 
3.2.3 Human lamin B2 S→D mutants 
3.2.3.1 Human lamin B2 S37D 
The human lamin B2 cDNA in pEYFP-C1 was used as a template for the mutagenesis 
reaction. The S37D (TCG>GAC) mutation was introduced by site-directed 
mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit (Stratagene, 
Germany) according to the manufacturer’s protocol (forward primer SG41: 5’-GCC 
ACGCCGCTGGACCCCACGCGCCTG-3’; reverse primer SG42: 5’-CAGGCGCGTGGGGTC 
CAGCGGCGTGGC-3’). The resulting cDNA sequence was verified by sequencing.  
 
3.2.3.2 Human lamin B2 S405D 
The human lamin B2 headless cDNA in pBluescript was used as a template for the 
mutagenesis reaction. The S405D (TCC>GAC) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG45: 5’-GAGGCTGAAGCTGGACCCCAGCCCATCC-3’; reverse primer SG46: 5’-GGA 
TGGGCTGGGGTCCAGCTTCAGCCTC-3’). The resulting cDNA construct was verified by 
sequencing. The human lamin B2 headless S405D cDNA was then digested with 
BglII/EcoRI and cloned into the human lamin B2-pEYFP-C1 plasmid cut with the 
same restriction enzymes.  
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3.2.3.3 Human lamin B2 S407D 
The human lamin B2 headless cDNA in pBluescript was used as a template for the 
mutagenesis reaction. The S407D (AGC>GAC) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG13: 5’-CTGAAGCTGTCCCCCGACCCATCCTCGCGCGTC-3’; reverse primer SG14: 5’-
GACGCGCGAGGATGGGTCGGGGGACAGCTTCAG-3’). The resulting cDNA construct 
was verified by sequencing. The human lamin B2 headless S407D cDNA was then 
digested with BglII/EcoRI and cloned into the human lamin B2-pEYFP-C1 plasmid cut 
with the same restriction enzymes.  
 
3.2.3.4 Human lamin B2 S37+405D 
The human lamin B2 S405D cDNA in pEYFP-C1 was digested using BglII/EcoRI and 
cloned into the human lamin B2 S37D-pEYFP-C1 plasmid cut with the same 
restriction enzymes. The construct was validated by sequencing. 
 
3.2.3.5 Human lamin B2 S37+407D 
The human lamin B2 S407D cDNA in pEYFP-C1 was digested using BglII/EcoRI and 
cloned into the human lamin B2 S37D-pEYFP-C1 plasmid cut with the same 
restriction enzymes. The construct was validated by sequencing. 
 
3.2.3.6 Human lamin B2 S405+407D 
The human lamin B2 headless S407D cDNA in pBluescript was used as a template for 
the mutagenesis reaction. The S405D (TCC>GAC) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG75: 5’-GAGGCTGAAGCTGGACCCCGACCCATCC-3’; reverse primer SG76: 5’-GGA 
TGGGTCGGGGTCCAGCTTCAGCCTC-3’). The resulting cDNA construct was verified by 
sequencing. The human lamin B2 headless S405+407D cDNA was then digested with 
BglII/EcoRI and cloned into the human lamin B2-pEYFP-C1 plasmid cut with the 
same restriction enzymes.  
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3.2.3.7 Human lamin B2 S37+405+407D 
The human lamin B2 S405+407D cDNA in pEYFP-C1 was digested with BglII/EcoRI 
and cloned into the human lamin B2 S37D-pEYFP-C1 plasmid cut with the same 
restriction enzymes. The construct was validated by sequencing.  
 
3.2.4 Human Lamin B1 
The human lamin B1 cDNA in pBluescript was amplified by PCR with a forward 
primer (SG73: 5’-GAGAGATCCGGAATGGCGACTGCGACCCC-3’) introducing a BspEI 
restriction site and a reverse primer (SG74: 5’-GAGAGACTCGAGCATAATTGCAC 
AGCTTC-3’) introducing a XhoI restriction site. The PCR fragment was digested with 
BspEI and XhoI and inserted into the multiple cloning site of pEYFP-C1. The 
construct was validated by sequencing. 
 
3.2.5 Human lamin B1 S→D mutants 
3.2.5.1 Human lamin B1 S23D 
The human lamin B1 cDNA in pBluescript was used as a template for the 
mutagenesis reaction. The S23D (AGC>GAC) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG57: 5’-CACCACGCCGCTGGACCCCACGCGCCTG-3’; reverse primer SG58: 5’-
CAGGCGCGTGGGGTCCAGCGGCGTGGTG-3’). The resulting cDNA construct was 
verified by sequencing. The human lamin B1 S23D cDNA was then amplified by PCR 
with a forward primer (SG73: 5’-GAGAGATCCGGAATGGCGACTGCGACCCC-3’) 
introducing a BspEI restriction site and a reverse primer (SG74: 5’-GAGAGA 
CTCGAGCATAATTGCACAGCTTC-3’) introducing a XhoI restriction site. The PCR 
fragment was digested with BspEI and XhoI and inserted into the multiple cloning 
site of pEYFP-C1. The construct was validated by sequencing. 
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3.2.5.2 Human lamin B1 S391D 
The human lamin B1 cDNA in pBluescript was used as a template for the 
mutagenesis reaction. The S391D (TCT>GAT) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG53: 5’-GAGGTTGAAGCTGGATCCAAGCCCTTCT-3’; reverse primer SG54: 5’-
AGAAGGGCTTGGATCCAGCTTCAACCTC-3’). The resulting cDNA construct was verified 
by sequencing. The human lamin B1 S391D cDNA was then amplified by PCR with a 
forward primer (SG73: 5’-GAGAGATCCGGAATGGCGACTGCGACCCC-3’) introducing a 
BspEI restriction site and a reverse primer (SG74: 5’-GAGAGACTCGAGCATAAT 
TGCACAGCTTC-3’) introducing a XhoI restriction site. The PCR fragment was 
digested with BspEI and XhoI and inserted into the multiple cloning site of pEYFP-C1. 
The construct was validated by sequencing. 
 
3.2.5.3 Human lamin B1 S393D 
The human lamin B1 cDNA in pBluescript was used as a template for the 
mutagenesis reaction. The S393D (AGC>GAC) mutation was introduced by site-
directed mutagenesis with the QuikChange II XL Site-Directed Mutagenesis kit 
(Stratagene, Germany) according to the manufacturer’s protocol (forward primer 
SG49: 5’-GAAGCTGTCTCCAGACCCTTCTTCCCGTG-3’; reverse primer SG50: 5’-CAC 
GGGAAGAAGGGTCTGGAGACAGCTTC-3’). The resulting cDNA construct was verified 
by sequencing. The human lamin B1 S391D cDNA was then amplified by PCR with a 
forward primer (SG73: 5’-GAGAGATCCGGAATGGCGACTGCGACCCC-3’) introducing a 
BspEI restriction site and a reverse primer (SG74: 5’-GAGAGACTCGAGCATAAT 
TGCACAGCTTC-3’) introducing a XhoI restriction site. The PCR fragment was 
digested with BspEI and XhoI and inserted into the multiple cloning site of pEYFP-C1. 
The construct was validated by sequencing. 
 
3.2.6 Human lamin A p.R321X 
The cloned full-length cDNA of human lamin A (McKeon et al, 1986) in pEYFP-C1 was 
used as a template for the mutagenesis reaction. The p.R321X (CGA>TGA) mutation 
was introduced by site-directed mutagenesis with the QuikChange II XL Site-Directed 
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Mutagenesis kit (Stratagene, Germany) according to the manufacturer’s protocol 
(forward primer SG112: 5’-CACCACGCCGCTGGACCCCACGCGCCTG-3’; reverse primer 
SG113: 5’-CAGGCGCGTGGGGTCCAGCGGCGTGGTG-3’). The resulting cDNA construct 
was verified by sequencing. 
 
3.3 Cell culture techniques 
3.3.1 Cultivation of culture cell lines 
Adherent cultured cells were grown in cell culture flasks in an incubator with 95% 
relative air humidity and 5% CO2 in DMEM medium supplemented with 10% FCS, 20 
mM L-glutamine and 100 µg/ml antibiotics. According to their doubling time, cells 
were split every 3 – 5 days to keep them in the logarithmic growth phase. For 
splitting, the culture medium was removed and the cells were washed with 1 x PBS. 
Cells were detached from the culture flask surface by incubation at 37°C in trypsin 
solution for 3 – 5 minutes. Trypsinized cells were resuspended in fresh, pre-warmed 
medium and transferred into new flasks, thereby diluted 1:5 to 1:10.  
 
3.3.2 Cultivation of embryonic stem cells 
The murine embryonic stem cells were cultured in DMEM-F12/Neurobasal medium 
supplemented with 1x Supplement B27, 50 µg/ml BSA fraction V, 100 µg/ml APO-
transferrin bovine,  25 µg/ml human recombinant insulin, 6 ng/ml progesterone, 16 
µg/ml putrescin, 30 nM Na-selenite, 2 mM glutamine, 0.15 mM 1-thioglycerol, 10 
ng/ml BMP-2 and LIF. Cells were routinely grown in an incubator with 95% relative 
air humidity and 5% CO2 on gelatinized flasks. Culture medium was changed every 
other day as long as the culture was thin; later on it was changed daily. Cells were 
split twice a week between 1:6 and 1:12. For splitting, the culture medium was 
removed and the cells were washed once with ES trypsin solution (0.025% trypsin/1 
mM EDTA) before they were incubated in ES trypsin solution at 37°C until they 
detached. Trypsin activity was stopped by adding a trypsin inhibitor and the cells 
were resuspended in fresh culture medium. Subsequently, cells were centrifuged for 
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2 minutes at 1200 rpm, the cell pellet was resuspended in fresh culture medium and 
the cells were transferred to new gelatinized flasks.  
 
3.3.3 Freezing of cells 
Cells were stored at -80°C or in liquid nitrogen. 
After trypsinization, the cells were resuspended in DMEM and centrifuged at 1000 
rpm for 5 minutes. The cell pellet was resuspended in 1.5 ml complete growth 
medium with 10% DMSO and transferred to 1.8 ml cryo tubes. After incubation for 
20 minutes at -20°C, the tubes were transferred to -80°C or liquid nitrogen. 
ES cells were trypsinized as usual. After centrifugation, the cell pellet was 
resuspended in culture medium and freezing medium (complete ES medium with 
20% DMSO) was added drop wise. 0.5-1 ml aliquots with approximately 2-4 million 
cells per cryo vial were placed in a “Mr. Frosty” container filled with isopropanol and 
placed at -80°C over night. The following day, the cryo tubes were transferred to 
liquid nitrogen. 
 
3.3.4 Thawing of cells 
Cryo tubes were thawed in a 37°C water bath. Cells were immediately transferred 
into a 50 ml Falcon tube with 10 ml pre-warmed (37°C) culture medium and 
centrifuged at 1000 rpm for 5 minutes. The cell pellet was resuspended in culture 
medium and transferred into a 5 ml cell culture flask and placed in the incubator. 
The following day the medium was replaced to remove dead cells and cell debris.  
 
3.3.5 Transfection of cells 
3.3.5.1 Transient transfection of cells 
Transient transfection of cultured cells was performed with FuGene6 transfection 
reagent (Roche, Germany). After transfection, cells were incubated under the normal 
growth conditions.  
For transient transfection of embryonic stem cells, Lipofectamine2000 (Invitrogen, 
Germany) was used according to the manufacturers instructions.  
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3.3.5.2 Stable transfection of cells 
Culture cell lines were transfected with FuGene6 transfection reagent (Roche, 
Germany) in 60 mm cell culture dishes. Cells were further incubated under normal 
growth conditions. After 2 days, cells were split onto two 10 cm cell culture dishes. 
For selection for stably integrated neomycin resistance genes, G418 was added to 
the culture medium the next day in a concentration of 0.5 mg/ml for SW13 cells and 
1 mg/ml for U2OS cells. 
ES cells were transfected with Lipofectamine2000 (Invitrogen, Germany) in 60 mm 
cell culture dishes. ES cells were further handled as described for culture cell lines. 
For selection for stably integrated neomycin resistance genes, G418 was added to 
the culture medium in a concentration of 350 µg/ml.  
 
3.4 Fixation of cells 
3.4.1 Methanol / Acetone fixation 
Methanol and acetone were cooled down to -20°C. Cells grown on coverslips were 
washed twice in PBS with 2 mM MgCl2 at room temperature and then fixed in ice cold 
methanol for 5 minutes. Cells were then transferred to acetone for 30 seconds and 
air dried.  
 
3.4.2 Formaldehyde fixation 
Fixation of cells with formaldehyde was used in order to better preserve the cell 
structure. Cells grown on coverslips were washed twice in PBS with 2 mM MgCl2 at 
room temperature and then fixed for 7 minutes in ice cold 4% formaldehyde in PBS 
(pH 6.8). After fixation, cells were washed three times in PBS with 2 mM MgCl2 and 
incubated in ice cold 0.1% Triton in PBS for 5 minutes. After permeabilization, cells 
were washed three times with PBS with 2 mM MgCl2. 
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3.5 Indirect immunofluorescence 
Coverslips with fixed cells were placed with the cell layer on the top side into a humid 
plastic chamber and incubated for 10 – 15 minutes with 10% goat serum in PBS to 
block unspecific antibody binding. After removal of the blocking solution, the cells 
were incubated with 20 µl of the appropriate primary antibody adequately diluted in 
PBS for 30 – 60 minutes. Coverslips were rinsed in PBS with 2 mM MgCl2 and 
afterwards put back into the humid incubation chamber. The secondary antibody was 
diluted in PBS. A total volume of 20 µl was applied to the cells and incubated 30 – 60 
minutes. Subsequently, DAPI stain was applied to the cells for 5 minutes. After 
rinsing three times in PBS with 2 mM MgCl2, the coverslips were dipped briefly into 
ddH2O and were either directly mounted or incubated for 1 minute in ethanol and air 
dried. Coverslips were mounted with Fluoromount G (SouthernBiotech, USA) on 
microscope slides. Slides were stored at 4°C. 
 
3.5.1 Double immunolocalization 
For simultaneous detection of two proteins in the same cell, the cells were prepared 
as described above. The two primary antibodies were selected to have no cross 
reactivity with each other, diluted and incubated together. The fluorescently labelled 
secondary antibodies were chosen in a way to have no overlapping emission spectra.  
 
3.6 Confocal laser scanning microscopy 
For a detailed 3D analysis, the cells were imaged with a LEICA TCS SPII confocal 
laser scanning microscope. The used fluorophores were excited using the respective 
laser in combination with the filter of the suitable wavelength. The fluorescence 
signal was detected using a photomultiplier (PMT). The detection range was adjusted 
manually. Before imaging, the offset of each PMT was controlled. During imaging the 
photomultiplier setting was constantly at 750 Volt and the laser excitation was 
minimized to keep photobleaching at a minimum and to avoid oversaturation of the 
images. The pinhole was constantly kept at 1 Airy. All images were made with the 
63x/1.3 oil objective. The digital images were processed using Adobe Photoshop 
(Adobe, San Jose, CA), ImageJ software, or Leica LSM software, respectively.  
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Table 7: Laser lines of the Leica TSC SPII confocal microscope 
 
3.7 Protein techniques 
3.7.1 Protein extraction of heart muscle tissue 
Frozen heart muscle tissue was disrupted and homogenized in ice cold lysis buffer 
(20 mM Tris/HCl, pH 7.4, 1% Triton X-100, 10% glycerol, 150 mM NaCl, 1 mM PMSF, 
1 μg/ml leupeptin, 1 μg/ml antipain, 1 μg/ml chymostatin, 1 μg/ml pepstatinA) and 
subjected to SDS-PAGE.  
3.7.2 Differential protein extraction 
All volumes are adjusted for protein extraction from a 10 cm cell culture dish. 
Confluently grown cells were washed twice with PBS with 25 µM pefabloc and 76 mM 
PMSF. Subsequently, cells were incubated in 1 ml lysis low buffer (50 mM MOPS, 10 
mM EGTA, 100 mM MgCl2, 0.02% NP-40, 2.85 mM PMSF, 0.5 mM pefabloc in 0.5x 
PBS) at room temperature for 2 minutes. The supernatant was removed and a 200 µl 
sample of it was boiled in 100 µl 3x Laemmli sample buffer for 3 minutes (fraction 1: 
soluble and extractable cytoplasmic proteins). The remaining buffer was discarded. 
The cells were then incubated in 1 ml ice cold lysis high buffer (50 mM MOPS, 100 
mM MgCl2, 0.1% NP-40, 2.85 mM PMSF, 0.5 mM pefabloc, 0.25 mg/ml DNase in 0.5x 
PBS) on ice for 3 minutes and were carefully resuspended from time to time. 200 µl 
5 M NaCl were added and incubated for another 3 minutes. The cells were scraped 
off the dishes with a rubber policeman and transferred to an eppendorf tube. A 100 
µl sample was taken from the cell lysate and mixed with 100 µl ddH2O and 100 µl 3x 
Laemmli sample buffer and was boiled for 3 minutes (fraction 2: cytoskeletal 
fraction). The remaining cell lysate was centrifuged at 13.000 rpm and 4°C for 15 
minutes. Subsequently, 100 µl supernatant were removed and mixed with 100 µl 
laser type wavelength (nm) fluorochromes and respective excitation (nm)
diode laser 405  DAPI (405) 
cadmium laser 443 CFP (443) 
argon laser 458, 478, 488, 514 GFP (488), Alexa 488 (488), YFP (514) 
helium neon laser 543 Cy 3 (543), Alexa 568 (543/561) 
helium neon laser 633 Cy 5 (633) 
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ddH2O and 100 µl 3x Laemmli sample buffer (fraction 3: high-salt and high-detergent 
soluble cytoskeletal fraction). The sample was then boiled for 3 minutes. The cell 
pellet was resuspended in 200 µl 3x Laemmli sample buffer with 600 mg/ml urea and 
was boiled for 3 minutes (fraction 4: insoluble cytoskeleton proper).  
 
3.7.3 Western blot 
Western blotting is a method used for the qualitative and quantitative detection of 
proteins using specific antibodies. Proteins, e.g. from cell extracts, are first separated 
by SDS-PAGE, then transferred to a PVDF membrane, and the proteins are 
subsequently detected with specific antibodies. 
 
3.7.3.1 Discontinuous polyacrylamide gel electrophoresis (SDS-PAGE) 
For SDS-PAGE under reducing conditions, gel solutions with 10% acrylamide in the 
resolving part were prepared using an acrylamide/bis-acrylamide solution (37.5:1). 
Protein samples were boiled for 5 minutes in Laemmli sample buffer and were loaded 
onto the gel together with a protein size marker (Broad Range 7701S; New England 
Biolabs, Germany). Electrophoresis was run at 25 mA without restriction of the 
impressed voltage.  
 
Table 8: Composition of 10% acrylamide gels (adequate volume for 5 minigels) 
Stacking gel  Resolving gel  
acrylamide 1.32 ml acrylamide 10 ml 
ddH2O 6.2 ml ddH2O 13 ml 
upper Tris 2.5 ml lower Tris 7.5 ml 
10% APS 0.1 ml 10% APS 0.3 ml 
10% TEMED 0.1 ml 10% TEMED 0.3 ml 
 
After electrophoresis, the gel was either stained with Coomassie staining solution or 
was soaked in borate transfer buffer for Western blot analysis.  
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3.7.3.2 Transfer of proteins to PVDF membranes and detection 
Electrophoretic transfer of proteins from polyacryamide gels to a polyvinylidene 
fluoride (PVDF) membrane was performed by use of a wet blot apparatus. The 
membrane was briefly activated in 100% ethanol and soaked in borate transfer 
buffer for 10-15 minutes. Transfer was carried out for 2 hours at 500 mA at room 
temperature. After the transfer, the membrane was stained with Ponceau-S in order 
to verify the transfer efficiency and was subsequently dried or directly used for 
protein detection.  
For protein detection with antibodies, the activated membrane was incubated in 
blocking solution (TBST, 5% non-fat milk powder) for 1 hour at room temperature or 
over night at 4°C on a rocking platform. The membrane was then incubated with the 
primary antibody (diluted in blocking solution according to Table 5) for 1 hour at 
room temperature. To remove unbound antibody, the membrane was washed three 
times in TBST and was subsequently incubated with the secondary antibody 
conjugated to horse radish peroxidase (HRP) for 1 hour at room temperature. After 
washing the membranes three times in TBST, the membrane was incubated in ECL 
(Enhanced Chemiluminescence) solution (NEN, Germany) according to the 
manufacturer’s instructions. The solution was drained off the membrane and the 
membrane was exposed to an X-ray film (Kodak X-OMAT AR5) which was 
subsequently developed.  
 
3.7.4 Immunoprecipitation 
For immunoprecipitation, 50 µl protein G sepharose beads were washed three times 
in ice cold PBS. 50 µl beads were either incubated with 1 ml α-lamin B2 antibody 
(X223) or with 1 ml cell lysate in IP buffer (50 mM MOPS, 100 mM MgCl2, 0.4% 
Triton X-100, 2.85 mM PMSF, 0.5 mM pefabloc, 0.25 mg/ml DNase in 0.5x PBS) for 1 
hour. Antibody coated beads were washed twice with ice cold PBS and once with IP 
buffer and were subsequently incubated either with the precleared cell lysate or IP 
buffer in a final volume of 1 ml. Immunoprecipitation was carried out in an overhead 
rotator for 2 hours. Beads were washed three times with ice cold IP buffer and twice 
with ice cold PBS and were resuspended in 40 µl 3x Laemmli loading buffer. All steps 
were performed at 4°C.  
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Proteins were isolated from the beads and denatured by boiling for 5 minutes and 
separated by SDS-PAGE. After electrophoresis, the gel was either stained with 
Coomassie staining solution or was processed for Western blot analysis.  
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4 Results 
4.1 Influence of lamin B2 deletion mutants 
We wanted to investigate the mechanism of lamin in vivo assembly, its influences on 
nuclear morphology, and its behavior during mitosis. Therefore we generated a 
series of lamin B2 deletion mutants and tested the influence of the expression of 
these mutant proteins on nuclear morphology in several cell lines, including U2OS, 
HeLa, SW13 and mouse embryonic stem (ES) cells. In Figure 5 a schematic overview 
of the lamin B2 deletion mutants evaluated in this thesis is given.  
By recombinant DNA technology we removed either a part of the head domain (first 
32 amino acids, Δ32head), the complete head domain (headless), or the tail domain 
(tailless). In one case both, the first 32 amino acids of the head domain and the tail 
domain have been removed (Δ32head/tailless). Another mutant represents the rod  
domain (Walther et al). All protein coding sequences were constructed as N-terminal 
fusions with spectral variants of the green fluorescent protein (GFP). The detailed 
description of the cloning strategy of the expression plasmids is presented in section 
 3.2. 
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Figure 5: Diagram showing the domain structure of lamin B2 and the generated 
deletion mutants. (A) Amino acid sequences of the complete N-terminus and two progressively 
deleted mutants and of the C-terminal end of coil 2B with part of the tail domain and a tail 
deleted mutant. Conserved sequences are depicted in red. (B) Schematic overview of generated 
lamin B2 deletion mutants. 
 
4.1.1 Lamin B2 head deletions  
In order to investigate the influence of the lamin head domain on cellular localization 
and morphology, U2OS, HeLa and SW13 cells were transfected with YFP-tagged 
lamin B2 Δ32head and lamin B2 headless expression plasmids, respectively. After 48 
hours of incubation, cells were fixed and analyzed by confocal laser scanning 
microscopy (CLSM). Although lamin B2 headless is devoid of a conserved 
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sequencethat is still present in lamin B2 Δ32head both mutants showed the same 
effects. In U2OS cells, both YFP-lamin B2 Δ32head protein (Figure 6 A + A’) and 
YFP-lamin B2 headless (Figure 6 B + B’) became localized at the nuclear rim which 
was identified as the boundary of the DAPI staining region, but were also massively 
present in a dot-like distribution throughout the nucleoplasm (Figure 6). 
Furthermore, the nuclei were highly lobulated and irregularly shaped. Overall 
chromatin distribution was not altered (Figure 6 A’ + B’). Expression of the mutant 
proteins did not interfere with cell cycle progression and mitosis (data not shown). 
Transfection of HeLa and SW13 cells showed similar results. These observations 
suggest that the lamin B2 head domain is dispensable for nuclear envelope 
localization of the lamin B2 protein. However, its incorporation into the nuclear 
lamina appears to be less efficient and if integrated interferes with proper lamina 
assembly.  
 
 
Figure 6: Patterns of YFP-lamin B2 Δ32head and YFP-lamin B2 headless transiently 
transfected in U2OS cells. (A) U2OS cell expressing YFP-lamin B2 Δ32head, (B) U2OS cell 
expressing YFP lamin B2 headless, (A’, B’) double staining with DAPI. Extranuclear DAPI staining 
represents DNA which was not taken up by the cells and is often observed upon transfection of 
cells with FuGene6. All images are confocal sections. Bars 10 μm. 
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4.1.2 Lamin B2 tail deletions  
The influence of the lamin tail domain on cellular localization and nuclear morphology 
of U2OS, HeLa and SW13 cells was studied by transient transfection with lamin B2 
tailless, lamin B2 Δ32head/tailless or lamin B2 rod YFP-expression plasmids. All 
constructs are devoid of the NLS, which is in the tail domain. Confocal microscopic 
analysis revealed that YFP-lamin B2 tailless protein was distributed throughout the 
nucleoplasm and the cytoplasm (Figure 7 A). The cytoplasmic signal appeared as a 
rather filamentous structure. Localization to the nuclear rim could not be observed. 
DAPI staining showed that nuclear shape was not impaired by the mutant protein, 
neither was chromatin distribution altered (Figure 7 A’). Mutants lacking either part 
of the head domain and the tail domain (LB2 Δ32head/tailless) (Figure 7 B + B’) or 
the complete head domain and the tail domain (LB2 rod) (Figure 7 C + C’) displayed 
the same phenotype as the tail domain deletion alone. Both mutant proteins were 
distributed throughout the nucleoplasm and formed filament-like structures in the 
cytoplasm. Expression of YFP-lamin B2 tail deletion mutants in SW13 and HeLa cells 
exhibited the same effects as observed in U2OS cells. Although tailless mutants are 
devoid of the NLS, nucleoplasmic distribution could be observed. We explain this by 
the presence of a conserved sequence motif at the end of coil 2 of the α-helical rod 
domain mediating nuclear localization (Rogers et al, 1995). Hence, the tail domain 
was necessary to direct ectopic lamin B2 protein to the nuclear envelope. This 
experiment clearly demonstrates further that the endogenous wild type lamin B2 is 
not able to recruit the mutant proteins to the nuclear lamina.  
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Figure 7: Patterns of YFP-lamin B2 tailless, YFP-lamin B2 Δ32head/tailless and YFP-
lamin B2 rod transiently transfected in U2OS cells. U2OS cells expressing (A) YFP-lamin B2 
tailless, (B) YFP-lamin B2 Δ32head/tailless, and (C) YFP-lamin B2 rod (all shown in green). (A’, B’, 
C’) double staining with DAPI. All images are confocal sections. Bar 10 μm. 
 
 
 
 
 
 
  Results 
46 
4.1.3 Effects of lamin B2 deletion mutants on the endogenous 
lamina 
To evaluate the effects of the head and/or tail deletions on the integrity of the 
nuclear lamina, U2OS cells were fixed 48 hours post transfection with the respective 
YFP-expression plasmids and were stained with antibodies specific for lamin B2 or 
lamin A/C. Immunofluorescence was analyzed by confocal microscopy. Lamin B2 
antibody staining co-localized with the YFP-signal of all tailless mutants in the 
nucleoplasm and the cytoplasm but additionally showed the expected rim stain 
(Figure 8). With the lamin B2 antibody used it was not possible to distinguish 
between endogenous lamin B2 and exogenous mutant lamin B2. It can thus not be 
excluded that at least part of the endogenous lamin B2 also localized to the 
cytoplasm and the nucleoplasm.  
Endogenous lamin A/C localization at the nuclear rim was not affected by any of the 
mutants except for YFP-lamin B2 tailless (Figure 9). In cells expressing this mutant, 
lamin A/C localized to the nuclear rim, but was also present in the cytoplasm (Figure 
9 D, see insert). The cytoplasmic lamin A/C staining was rather weak and co-
localized with the YFP signal of the tail deletion mutant. Since synthesis and 
posttranslational processing of lamins take place in the cytoplasm it is conceivable 
that newly synthesized lamin A forms heteropolymers with the mutant lamin B2 
protein in the cytoplasm. This observation suggests that the lamin B2 head domain is 
necessary for the formation of heteropolymers with lamin A. This experiment clearly 
demonstrates further that a functional lamina can be built up in the presence of 
tailless lamin B2 mutants.  
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Figure 8: Double labeling of YFP-lamin B2 deletion mutants and lamin B2. Confocal 
sections of U2OS cells (A) untransfected, expressing (B) YFP-lamin B2 Δ32head, (C) YFP-lamin B2 
headless, (D) YFP-lamin B2 tailless, (E) YFP-lamin B2 Δ32head/tailless, (F) YFP-lamin B2 rod (all 
shown in green), stained with an antibody specific for lamin B2 (red). Bars 10 μm. 
 
Figure 9: Double labeling of YFP-lamin B2 deletion mutants and lamin A/C. Confocal 
sections of U2OS cells (A) untransfected, expressing (B) YFP-lamin B2 Δ32head, (C) YFP-lamin B2 
headless, (D) YFP-lamin B2 tailless, (E) YFP-lamin B2 Δ32head/tailless, (F) YFP-lamin B2 rod (all 
shown in green), stained with an antibody specific for lamin A/C (red). Bars 10 μm. 
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4.1.4 Effect of lamin B2 deletion mutants on endogenous NE 
proteins 
Lamins have been shown to interact with several integral membrane proteins of the 
inner nuclear membrane (Gruenbaum et al, 2003). To study the effects of the lamin 
head and/or tail deletions on the organization of inner nuclear membrane proteins in 
the nuclear envelope, U2OS cells were fixed 48 hours post transfection with the 
respective YFP-expression plasmids and were stained with antibodies specific for LBR 
(Figure 10) or emerin (Figure 11). LBR localization was not disturbed by any of the 
tailless lamin B2 mutants (Figure 10 D, E, F). However, in cells expressing YFP-lamin 
B2 Δ32head and YFP-lamin B2 headless LBR was indeed mainly localized at the 
nuclear envelope but was in addition massively found at the ER (compare Figure 10 
A to  B + C). This suggests that incorporation of headless lamin B2 mutants into the 
nuclear envelope interferes with proper nuclear envelope organization and thus leads 
to a redistribution or retention after synthesis of LBR in the ER. In contrast, emerin 
distribution was not influenced neither by the presence of head deleted lamin 
mutants nor by tail deleted lamin mutants (Figure 11).  
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Figure 10: Double labeling of YFP-lamin B2 deletion mutants and LBR. Confocal sections 
of U2OS cells (A) untransfected, expressing (B) YFP-lamin B2 Δ32head, (C) YFP-lamin B2 
headless, (D) YFP-lamin B2 tailless, (E) YFP-lamin B2 Δ32head/tailless, (F) YFP-lamin B2 rod (all 
shown in green), stained with an antibody specific for LBR (red). Bars 10 μm. 
 
Figure 11: Double labeling of YFP-lamin B2 deletion mutants and emerin. Confocal 
sections of U2OS cells (A) untransfected, expressing (B) YFP-lamin B2 Δ32head, (C) YFP-lamin B2 
headless, (D) YFP-lamin B2 tailless, (E) YFP-lamin B2 Δ32head/tailless, (F) YFP-lamin B2 rod (all 
shown in green), stained with an antibody specific for emerin (red). Bars 10 μm. 
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4.1.5 Biochemical characterization of lamin B2 deletion 
mutants 
U2OS cells were transfected 48 hours prior to differential protein extraction (see 
section 3.7.1). The transfection efficiency was estimated to be 70-90%. The gained 
fractions 1-4 were subjected to SDS-PAGE in aliquot amounts and were analyzed in a 
Western blot by using an antibody specific for lamin B2 (Figure 12). In extracts of 
cells expressing YFP-lamin B2 wild type (WT) both, YFP-lamin B2 WT and 
endogenous lamin B2 protein were detectable in cytoskeletal fractions 2 and 4 
(Figure 12 A). In cell extracts of YFP-lamin B2 Δ32head (Figure 12 B) and YFP-lamin 
B2 headless (Figure 12 C) expressing cells the mutant protein was primarily 
detectable in fractions 2-4. However, a weak signal could also be detected in fraction 
1 indicating that a small amount of the mutant protein is cytoplasmic. It can be 
concluded that partial or complete deletion of the head domain of lamin B2 increases 
the solubility of the protein. Endogenous lamin B2 protein was primarily detectable in 
fractions 2 and 4 and to a smaller extent also in fraction 3 (Figure 12 B + C). Thus, 
expression of lamin B2 head deletion mutants increases the solubility of endogenous 
lamin B2 protein. The relative amount of the YFP-tagged fusion proteins was several 
folds higher than that observed for endogenous lamin B2 protein.  
Western blot analysis of extracts of cells expressing YFP-lamin B2 tailless (Figure 12 
D) and YFP-lamin B2 rod (Figure 12 E) revealed that the mutant proteins could not 
be separated from endogenous lamin B2 by the SDS-PAGE system used. It is thus 
not possible to make a statement about the solubility of tail deleted lamin B2 
mutants and its influence on endogenous lamin B2 protein. The lower band detected 
in the Western blots most likely represents a degradation product as it was also 
detected by an antibody specific for GFP (data not shown).  
 
  Results 
51 
Figure 12: Western blot analysis of differentially extracted fractions from U2OS cells 
expressing YFP-lamin B2 deletion mutants using an antibody specific for lamin B2. 
Extracts of U2OS cells expressing (A) YFP-lamin B2 WT, (B) YFP-lamin B2 Δ32head, (C) YFP-lamin 
B2 headless, (D) YFP-lamin B2 tailless, (E) YFP-lamin B2 rod. Lane 1, soluble and extractable 
cytoplasmic proteins, lane 2, total cytoskeletal fraction, lane 3, high-salt and high-detergent 
soluble cytoskeletal fraction, lane 4, insoluble cytoskeleton proper. It should be considered that 
the signal intensities of the different immunoblots can not be compared directly, since the 
exposure times of the X-ray film varied between cell preparations. 
 
4.1.6 Expression of lamins in mouse embryonic stem (ES) cells 
Mouse embryonic stem cells are derived from the inner cell mass of the blastocyst 
stage of the embryo. They possess a unique characteristic distinguishing them from 
other cells: They have the dual abilities to self-renew and give rise to new pluripotent 
ES cells, and to differentiate into all specialized cell types found in the adult mouse. A 
further feature of ES cells is their exhibition and maintenance of a full (diploid), 
normal complement of chromosomes. In order to study localization of YFP-tagged 
wild type lamin B1 or lamin B2 respectively, and their influences on nuclear 
morphology, ES cells were transiently transfected with the respective expression 
plasmids. Before fixation, cells were dissociated into single cells and transferred on 
matrigel-coated coverslips, and were allowed to settle. Confocal microscopic analysis 
showed that both YFP-lamin B2 (Figure 13 A) and YFP-lamin B1 (Figure 13 C) protein 
localized to the nuclear rim as expected. However, the thickness of the nuclear 
envelope varied between cells, in some cells appearing as a rather thick structure. 
Chromatin distribution as revealed by DAPI staining remained unaffected.  
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In order to study the fate of ES cells stably expressing YFP-lamin B1 or YFP-lamin B2, 
respectively, stable cell lines were generated as described in  3.3.5.2 and were 
analyzed by confocal microscopy. Both, lamin B2 (Figure 13 B) and lamin B1 (Figure 
13 D) YFP fusion proteins localized to the nuclear rim as observed after transient 
transfection of the respective expression plasmid. Stably expressing cells showed no 
variation in the thickness of the nuclear envelope. Also chromatin distribution was 
not affected as revealed by DAPI staining. ES cells stably expressing YFP-lamin B2 or 
YFP-lamin B1 did not show a higher tendency to differentiate when compared to 
untransfected cells as analyzed by morphological criteria.   
 
 
Figure 13: Patterns of YFP-lamin B2 and YFP-lamin B1 in mouse ES cells. (A+B) 
localization of YFP-lamin B2 in (A) transiently transfected and (B) stably expressing ES cells 
(shown in green). (C+D) localization of YFP-lamin B1 in (C) transiently transfected and (D) stably 
expressing ES cells (shown in green). DAPI staining is shown in blue. All images are confocal 
sections. Bar 5μm. 
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4.1.7 Effects of lamin B2 head and/or tail deletion on their 
cellular localization and nuclear morphology in ES cells 
To evaluate the effects of lamin B2 head and/or tail deletions on their cellular 
localization and nuclear morphology in ES cells, cells were transfected with the 
respective expression plasmids and were transferred to matrigel-coated coverslips 
44-48 hours thereafter.  
 
 
Figure 14: Patterns of YFP-lamin B2 deletion mutants in ES cells. (A) YFP-lamin B2 
Δ32head, (B) YFP-lamin B2 headless, (C) YFP-lamin B2 tailless, (D) YFP-lamin B2 rod (all shown in 
green). DAPI staining is shown in blue. All images are confocal sections. Bar 5μm. 
 
The YFP-lamin B2 Δ32head mutant localized to the nuclear rim, as seen in confocal 
mid-sections (Figure 14 A). In some cells the mutant protein formed single small 
aggregates along the nuclear lamina. Nuclear shape remained unaffected. ES cells 
transfected with the YFP-lamin B2 headless construct also showed a clear nuclear rim 
staining (Figure 14 B). Nuclei were slightly less regularly shaped and in some cells 
invaginations of the nuclear envelope were observed. The tailless lamin B2 mutants, 
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YFP-lamin B2 tailless (Figure 14 C) and YFP-lamin B2 rod (Figure 14 D), were both 
diffusely distributed throughout the nucleoplasm and the cytoplasm. Nuclear rim 
stain was not observed. All four lamin deletion mutants did not affect overall 
chromatin distribution as revealed by DAPI staining. These results demonstrate again 
that the head domain is dispensable for nuclear localization and integration of lamin 
B2 protein into the nuclear envelope of ES cells. In contrast, the tail domain is 
necessary for nuclear envelope localization and integration.  
 
4.2 The effect of mutations at the phosphoacceptor sites of 
lamins 
With the onset of mitosis, lamins become phosphorylated and the lamina 
disassembles. In order to study the fate of cells expressing lamin mutants 
permanently mimicking the mitotic phosphorylated state, several lamin B1 and lamin 
B2 mutants were generated. Thereby we aimed to study if a nuclear lamina can be 
built up in the presence of these lamin mutants. Here, the three mitotic Cdk1 
phosphoacceptor sites flanking the rod domain in human lamin B1 and lamin B2 
were changed from serine (S) to aspartic acid (D) by site-directed mutagenesis. In 
Figure 15 a schematic overview of the lamin B1 and lamin B2 S→D mutants 
evaluated in this thesis is given. All protein coding sequences were constructed as N-
terminal fusions with spectral variants of the green fluorescent protein (GFP). For 
lamin B1 three different single mutants were generated, namely S23D, S391D, and 
S393D. For lamin B2 all single (S37D, S405D, S407D), double (S37+405D, 
S37+407D, S405+407D), and triple (S37+405+407D) mutants were generated. The 
detailed description of the cloning strategy of the expression plasmids is presented in 
section  3.2. In the following, lamin S→D mutants will be referred to as “mitotic” 
lamin mutants.  
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Figure 15: Schematic overview of mutated mitotic phosphoacceptor sites in lamins. 
Positions of amino acid exchanges are depicted in red for lamin B1 and in black for lamin B2, 
respectively. 
 
4.2.1 Influence of mitotic lamin B2 mutants on nuclear 
localization and morphology 
To evaluate the effects of lamin B2 mutants mimicking the phosphorylated state on 
localization and nuclear morphology, U2OS cells were transfected with the YFP-lamin 
B2 S407D expression plasmid and fixed 9 and 24 hours thereafter. In cells fixed after 
9 hours, the mutant protein localized to intranuclear aggregates (Figure 16 A + B). 
In few cells, the mutant lamin protein localized to the nuclear rim, similar to wild 
type lamin B2 (Figure 16 C). In these cells, nuclear shape was impaired since nuclei 
were lobulated and showed invaginations of the nuclear lamina. After 24 hours, YFP-
lamin B2 S407D also aggregated inside the nucleus, in most cells forming single large 
lamin territories (Figure 16 D – F). Some of these aggregations appeared to be 
attached to the nuclear envelope, whereas others were not as analyzed by confocal 
microscopy. Most of the aggregates were larger than those observed in cells fixed 
after 9 hours. Nuclear shape was not affected, neither after 9 hours nor after 24 
hours.  
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Figure 16: Pattern of YFP-lamin B2 S407D in U2OS cells. (A-C) cells fixed 9 hours post 
transfection, (D-F) cells fixed 24 hours post transfection. All images are confocal sections.       
Bars 10 μm. 
 
Cells transfected with YFP-lamin B2 S37D, S405D, S37+405D, S37+407D, 
S405+407D, or S37+405+407D expression plasmids were fixed 24 hours thereafter 
and analyzed by confocal microscopy (data not shown). Localization of all YFP-lamin 
B2 S→D mutants was indistinguishable from the lamin S407D mutant. Thus, a single 
amino acid exchange on mitotic phosphorylation sites from serine to aspartic acid 
seems to be sufficient to cause intranuclear and membrane associated aggregation 
of the mutant protein. This effect was independent of both, the position of the 
mutated site and the number of mutated sites.  
Long-term cultivation of transiently transfected cells under standard conditions 
showed that cells expressing “mitotic” lamin B2 mutants are viable and thus must be 
able to undergo mitosis (not shown). 
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4.2.2 Generation of stable cell lines 
In order to characterize whether the large aggregations formed by lamin B2 proteins 
mutated from serine to aspartic acid in mitotic phosphoacceptor sites, are due to 
overexpression of the protein and if cells expressing these mutants are still able to 
undergo mitosis, stable U2OS cell lines were generated and analyzed by confocal 
microscopy (Figure 17). YFP-lamin B2 S37+407D protein localized to the nuclear rim, 
but also aggregated along the nuclear lamina and in the nucleoplasm (Figure 17 A + 
B). Aggregations varied in size, but were not as large as observed upon transient 
transfection. Due to the clone heterogeneity, in some cells localization of YFP-lamin 
B2 S37+407D was restricted to the nuclear rim (Figure 17 C + D). Nuclear shape 
was impaired by YFP-lamin B2 mimicking the phosphorylated state. Some nuclei 
were kidney-like shaped or were highly lobulated (Figure 17 A + B), whereas others 
showed large invaginations and had a donut-like shape (Figure 17 C + D).  
 
 
Figure 17: Confocal sections of U2OS cells stably expressing YFP-lamin B2 S37+407D. 
Bars 10 μm. 
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4.2.3 Influence of “mitotic” lamin B1 mutants on nuclear 
localization and morphology 
In man almost all cells express another B-type lamin besides lamin B2, namely lamin 
B1. To investigate the localization of transiently expressed lamin B1 mutated in 
mitotic phosphoacceptor sites from serine to aspartic acid, U2OS cells were 
transiently transfected with YFP-lamin B1 S23D, S391D, or S393D and were fixed 24 
hours thereafter (Figure 18). 
 
 
Figure 18: Patterns of YFP-lamin B1 mutated in mitotic phosphorylation sites from 
serine to aspartic acid in U2OS cells. Confocal sections of cells expressing (A) YFP-lamin B1 
S37D, (B + D) YFP-lamin B1 S391D, (C) YFP-lamin B1 S393D. Bars 10 μm. 
 
The YFP-lamin B1 S37D protein localized to intranuclear aggregates (Figure 18 A). 
These aggregates were generally smaller than those observed for lamin B2 mutated 
in the corresponding mitotic phosphoacceptor sites. YFP-lamin B1 S391D (Figure 18 
B) and YFP-lamin B1 S393D (Figure 18 C) also localized to intranuclear aggregates. 
In some cells the YFP-lamin B1 S→D protein accumulated and aggregated also in the 
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cytoplasm (Figure 18 D). The nuclear morphology was not affected. As observed for 
YFP-lamin B2 S→D mutants, localization of YFP-lamin B1 S→D protein was 
independent of the position of the mutated site.  
 
4.2.4 Effect of “mitotic” lamin expression on the endogenous 
lamina 
In order to study the effects of lamin B1 and lamin B2 mutated in mitotic 
phosphoacceptor sites on the integrity of the nuclear lamina, U2OS cells were fixed 
16-18 hours post transfection with the respective expression plasmids and stained 
with antibodies specific for lamin B2 or lamin A/C (Figure 19). Since all “mitotic” 
lamin B2 mutants showed the same effects on nuclear localization and morphology 
representative examples will be shown in the following figures. “Mitotic” lamin B1 
mutants will be proceeded the same way. In cells expressing YFP-lamin B2 S407D 
the endogenous lamin B2 was absent from the nuclear rim. Instead, it localized at 
the rim of the aggregates formed by the mutant protein (Figure 19 A). In contrast, 
endogenous lamin A/C was still present at the nuclear rim but was also, to some 
extent, recruited to the aggregates formed by the mutant lamin protein (Figure 19 
B). In cells expressing YFP-lamin B1 S391D, nuclear rim localization of endogenous 
lamin B2 remained unaffected (Figure 19 C). The endogenous lamin A/C protein 
localized to the nuclear rim but also co-localized with the intranuclear aggregates 
formed by the mutant protein (Figure 19 D). The co-localization of lamin B2 and 
lamin B1 mutated in phosphoacceptor sites with lamin A/C suggests an interaction 
between these proteins that depends on the presence of the “mitotic” signal.  
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Figure 19: Double labeling of lamin B2 and lamin B1 phosphoacceptor mutants and 
nuclear lamins. Confocal sections of U2OS cells transfected with YFP-fusion proteins of lamin B2 
S407D (A) or S37+405D (B) or lamin B1 S391D (C + D) (shown in green), and stained with 
antibodies specific for lamin B2 (A + C) or lamin A (B + D) (shown in red). Bars 10 μm. 
 
4.2.5 Effect of “mitotic” lamin expression on endogenous NE 
proteins 
In order to investigate if the distribution of inner nuclear membrane proteins was 
affected by the presence of “mitotic” lamin proteins, U2OS cells were fixed 16-18 
hours post transfection with the respective expression plasmids and stained with 
antibodies specific for LBR, emerin, or Nup153 (Figure 20). In cells expressing YFP-
lamin B2 S37+407D both, endogenous emerin and LBR were localized at the nuclear 
rim (Figure 20 A + B). However, rim staining was not homogeneously and was 
interrupted at sites of lamin aggregates that appeared to be attached to the nuclear 
envelope. Nup153 also localized to the nuclear rim as expected but in contrast to 
LBR and emerin was accumulated at sites of aggregates formed by the mutant 
protein (Figure 20 C).  
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Cells transfected with the YFP-lamin B1 S391D expression plasmid showed no 
alterations in LBR, emerin, or Nup153 localization (Figure 20 E - F).  
 
Figure 20: Double labeling of lamin B1 and lamin B2 phosphoacceptor mutants with 
NE proteins. Confocal sections of cells transfected with YFP-lamin B2 S37+407D (A – C, shown 
in green) or YFP-lamin B1 S391D (D – F, shown in green) respectively, and stained with 
antibodies specific for LBR (A + D), emerin (B + E), Nup153 (C + F) (shown in red). Bars 10 μm. 
 
4.2.6 In vivo dynamics of aggregate formation 
The investigation of “mitotic” lamin B2 mutants in U2OS cells showed that these 
mutants formed large aggregates in the nucleus after about 24 hours post 
transfection of the respective expression plasmids. In order to analyze the process of 
the formation and the mobility of these aggregates in more detail, U2OS cells were 
transiently transfected with the YFP-lamin B2 S407D expression plasmid and directly 
processed for live cell imaging. The cells were observed by confocal imaging in 3D 
with a time lapse of 30 minutes. Formation and mobility of nuclear aggregates was 
analyzed in maximum projections of the 3D stacks (Figure 21). From about 4-5 hours 
on post transfection the mutant protein was observed to be expressed in significant 
amounts. At 11 hours after transfection the formed aggregates varied in size but 
were still relatively small (Figure 21 A). However, the aggregates grew over time and 
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fused when in spatial proximity (Figure 21: B - F, aggregates about to fuse are 
indicated by arrows). The number of aggregates decreased, resulting in some of the 
cells in the formation of single large lamin territories (Figure 21: compare E (18 
aggregates) to F (9 aggregates)). These reorganization events were very dynamic. 
The nuclei became very mobile and reversibly formed large lobulations (Figure 21 C).  
 
Figure 21: In vivo dynamics of YFP-lamin B2 S407D aggregate formation in U2OS 
cells. Maximum projections of 3D stacks. Time points indicated are post transfection. Arrows 
indicate aggregates about to fuse. Bar 10 μm. 
 
4.2.7 Aggregate formation leads to drastic chromatin 
reorganization 
Lamins are thought to be involved in chromatin organization (Bridger et al, 2007). In 
order to study changes in chromatin distribution due to aggregate formation in U2OS 
cells expressing YFP-lamin B2 S407D, fixed cells were stained with DAPI and 
analyzed by immunofluorescence. Confocal microscopy of the DAPI staining revealed 
that chromatin is excluded from areas where YFP-lamin B2 S407D aggregates are 
formed (Figure 22 A). The aggregates are spatially confined from chromatin, thus 
occupying a chromatin-free nuclear space. Chromatin distribution was also analyzed 
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in U2OS cells stably expressing a CFP fusion protein of histone H2A (Figure 22 B). 
For this purpose a U2OS cell line stably expressing a CFP fusion protein of histone 
H2A was generated and was transiently transfected with the YFP-lamin B2 S407D 
expression plasmid. Confocal microscopy showed that CFP-H2A was eliminated from 
areas of aggregate formation. Thus it is concluded that YFP-lamin B2 S407D 
accumulation takes place in the interchromosomal domain (ICD) compartment, 
eventually occupying a chromatin-free nuclear space. 
 
Figure 22: Chromatin organization in U2OS cells expressing YFP-lamin B2 S407D. (A) 
chromatin distribution revealed by DAPI staining (blue), (B) chromatin distribution in U2OS cells 
stably expressing CFP-H2A (blue). All images are confocal sections. Bars 10 μm. 
 
4.2.8 Co-transfection of lamin B1 and lamin B2 
Both, lamin B1 S→D mutants as well as lamin B2 S→D mutants formed intranuclear 
aggregates upon expression in U2OS cells. In order to study the spatial relationship 
of lamin B1 S→D mutants with lamin B2 S→D mutants and to find out whether the 
aggregates co-localize, co-transfection with both constructs was performed. U2OS 
cells were co-transfected with GFP-lamin B2 S407D and mCherry-lamin B1 S393D, 
fixed 24 hours thereafter and analyzed by confocal microscopy (Figure 23). The 
aggregates formed by the mutants were similarly distributed throughout the nucleus 
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and appeared to occupy the same nuclear space. However, analysis of confocal 
stacks in z showed that the GFP-lamin B2 S407D and mCherry-lamin B1 S393D 
signals did not co-localize completely (see insets Figure 23). Hence, both proteins 
were rather in very close proximity to each other, overlapping on the borders of the 
aggregates. These observations suggest that both proteins occupy the same nuclear 
space but they do not intermingle.  
 
Figure 23: Single confocal sections of a U2OS cell co-expressing GFP-lamin B2 S407D 
(green) and mCherry-lamin B1 S393D (red).  Bar 10 μm. 
 
4.2.9 Co-transfection of “mitotic” lamins with NLS-vimentin 
Several of the “mitotic” lamin B mutants fused to mCherry were also investigated 
concerning their co-localization to other ectopically expressed proteins. To this aim 
mCherry-lamin B1 S393D and GFP-Xenopus laevis NLS-vimentin were co-transfected 
in U2OS cells and fixed 24 hours thereafter (Figure 24 A). mCherry-lamin B1 S393D 
assembled into larger intranuclear aggregates, whereas GFP-Xenopus laevis NLS-
vimentin was visible as small intranuclear dots. The GFP-Xenopus laevis NLS-
vimentin dots surrounded the mCherry-lamin B1 S393D aggregates but could also be 
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observed apart from the aggregates. Hence, they co-localized but were not 
deposited into the same aggregate.  
Co-transfection of mCherry-lamin B2 S407D and GFP-Xenopus laevis NLS-vimentin 
showed similar results (Figure 24 B). mCherry-lamin B2 S407D appeared as irregular 
aggregates throughout the nucleus. These aggregates co-localized with GFP-Xenopus 
laevis NLS-vimentin, but did not intermingle. These results indicate that ectopically 
co-expressed mCherry-lamin B2 S407D or mCherry-lamin B1 S393D respectively, and 
GFP- Xenopus laevis NLS-vimentin occupy the same nuclear space, i.e. the ICD but 
are processed and sorted differently.  
 
Figure 24: Confocal sections of U2OS cells co-expressing (A) mCherry-lamin B1 S393D 
(red) and GFP-Xenopus laevis NLS-vimentin (green), (B) mCherry-lamin B2 S407D 
(red) and GFP-Xenopus laevis NLS-vimentin (green). Arrows point to GFP-Xenopus laevis 
NLS-vimentin dots lying next to lamin aggregates. Arrowheads indicate single GFP-Xenopus laevis 
NLS-vimentin dots. Bars 10 μm. 
 
4.2.10 Effects of mitotic lamin expression on PCNA localization 
Nuclear lamins are thought to play a role in DNA replication. Several laboratories 
have demonstrated that nuclear lamin proteins are essential for DNA replication in 
Xenopus egg extracts. Without lamin proteins, nuclear membranes assemble around 
Xenopus sperm chromatin but do not initiate replication. In one case it was shown 
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that the replication fork protein PCNA (proliferating cell nuclear antigen) is relocated 
from replication centers to intranuclear lamin aggregates (Spann et al, 1997). Izumi 
et al. (2000) showed in mammalian cells that dominant negative lamin B1 mutants 
trapped PCNA into intranuclear aggregates. In order to investigate whether “mitotic” 
lamin B2 sequesters PCNA from replication centers, fixed cells were analyzed by 
confocal microscopy. U2OS cells transiently transfected with YFP-lamin B2 S407D 
were fixed 24 hours thereafter and stained with an antibody specific for PCNA 
(Figure 25 A). YFP-Lamin B2 S407D trapped PCNA into intranuclear aggregates. In 
cells co-expressing YFP-lamin B2 S407D and CFP-PCNA, PCNA protein was also 
recruited into the aggregates formed by YFP-lamin B2 S407D (Figure 25 B).  
 
Figure 25: Double labeling of YFP-lamin B2 S407D and PCNA. (A) U2OS cell expressing 
YFP-lamin B2 S407D (green in merge) stained with an antibody specific for PCNA (red in merge), 
(B) U2OS cells co-transfected with YFP-lamin B2 S407D (green in merge) and CFP-PCNA (red in 
merge). All images are confocal sections. Bars 10 μm. 
 
4.2.11 Biochemical analysis of cells expressing mitotic lamin 
mutants 
In order to characterize the solubility of “mitotic” lamin B2 mutants, transiently 
transfected U2OS cells were subjected to differential protein extraction (see  3.7.2). 
Cells have been transfected with the respective expression plasmid about 18-22 
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hours before the extraction procedure, with an estimated transfection efficiency of 
about 80-90%. Fractions 1-4 were analyzed in a Western blot by detection with an 
antibody specific for lamin B2 (Figure 26).  
 
Figure 26: Western blot analysis of differentially extracted fractions from U2OS cells 
expressing YFP-lamin B2 mutants mimicking the mitotic phosphorylated state using 
an antibody specific for lamin B2. Extracts of U2OS cells expressing YFP fusion proteins of (A) 
lamin B2 WT, (B) lamin B2 S37D, (C) lamin B2 S405D, (D) lamin B2 S407D, (E) lamin B2 
S37+405D, (F) lamin B2 S37+407D, (G) lamin B2 S405+407D, (H) lamin B2 S37+405+407D. 
Lane 1, soluble and extractable cytoplasmic proteins, lane 2, total cytoskeletal fraction, lane 3, 
high-salt and high-detergent soluble cytoskeletal fraction, lane 4, insoluble cytoskeleton proper. It 
should be considered that the signal intensities of the different immunoblots can not be compared 
directly, since the exposure times of the X-ray film varied between cell preparations. 
 
In contrast to YFP-lamin B2 WT which was detectable in fractions 2 and 4 (Figure 26 
A), YFP-lamin B2 proteins mutated from serine to aspartic acid in mitotic 
phosphoacceptor sites was detectable in fractions 2-4 (Figure 26 B-H). This higher 
solubility could be observed in extracts of all mutants analyzed, independent of both 
the position of the mutated site and the number of mutated sites. Endogenous lamin 
B2 protein was detectable in fractions 2 and 4 and its solubility was thus not affected 
by the expression of YFP-lamin B2 proteins mutated in mitotic phosphoacceptor sites. 
The relative amount of the YFP-fusion proteins was several folds higher than 
endogenous lamin B2. These results clearly demonstrate that “mitotic” lamin B2 
mutants do not form co-polymers with endogenous lamin B2. 
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4.2.12 Identification of interaction partners of soluble lamins 
Lamin B2 YFP-fusion proteins mimicking the mitotic phosphorylated state have been 
shown to be more soluble than wild type lamin B2 or endogenous lamin B2 protein. 
Furthermore, they are localized in a chromatin-free nuclear space. In order to 
identify possible interaction partners of these so-called soluble lamins, which might 
be responsible for the formation and sorting of the protein into intranuclear lamin 
aggregates, a co-immunoprecipitation assay was performed followed by MALDI 
analysis. To optimize the cell extraction conditions for the subsequent co-
immunoprecipitation, U2OS cells transfected with the YFP-lamin B2 S407D expression 
plasmid were sequentially extracted with an extraction buffer containing 10 mM 
MgCl2 and 0.2, 0.4, 0.6, 0.8, and 1% Triton X-100, respectively. The gained fractions 
were analyzed in a Western blot by detection with an antibody specific for lamin B2 
(Figure 27 A). A certain amount of YFP-lamin B2 S407D protein with a size of about 
97 kD could already be solubilized with 0.2% and 0.4% Triton X-100. In contrast, 
endogenous lamin B2 could not be extracted with any of the applied Triton X-100 
concentrations and resided completely in the insoluble pellet fraction. Western blot 
analysis with an antibody specific for lamin B2 of extracts of untreated cells, cells 
expressing wild type YFP-lamin B2, and cells expressing YFP-lamin B2 S407D showed 
that 0.4% Triton was sufficient to extract a high portion of YFP-lamin B2 S407D 
protein being thus present in the supernatant (Figure 27 B). On the contrary, wild 
type YFP-lamin B2 and endogenous lamin B2 (control) remained unaffected and 
resided completely in the insoluble pellet fraction. These results suggest that wild 
type and endogenous lamin B2 are in a membranous state.  
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Figure 27: Western blot analysis of Triton X-100 extracted U2OS cells expressing YFP-
lamin B2 S407D. (A) Sequential Triton X-100 extraction (0.2%, 0.4%, 0.6%, 0.8%, 1%, 
insoluble Pellet (P)) of cells expressing YFP-lamin B2 S407D. (B) Extracts of wild type cells, cells 
expressing wild type YFP-lamin B2, and cells expressing YFP-lamin B2 S407D were treated with 
0.4% Triton X-100 and processed for soluble and cytoskeletal fractions, P pellet, S supernatant. 
 
Figure 28: Co-immunoprecipitation of Triton X-100 extracted U2OS cells expressing 
YFP-lamin B2 S407D using an antibody specific for lamin B2. (A) Immunoprecipitation 
with an antibody specific for lamin B2, (B) Coomassie staining of immunoprecipitation. Numbers 
1-7 indicate the bands cut out for MALDI analysis. PC preclearing sample, IP immunoprecipitation 
sample, AC antibody control sample. 
 
For the co-immunoprecipitation assay cells expressing YFP-lamin B2 S407D were 
extracted as described above and the supernatant containing the soluble lamin 
complexes was subsequently subjected to immunoprecipitation with an antibody 
specific for lamin B2 as described in  3.7.4. The immunoprecipitation sample (IP), the 
preclearing sample (PC) and the antibody control sample (AC) were analyzed in a 
Western blot by detection with an antibody specific for lamin B2 (Figure 28 A). YFP-
lamin B2 S407D protein could not be detected in the preclearing sample, thus 
excluding unspecific binding of the protein to the protein G sepharose beads. 
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Immunoprecipitation targeted against lamin B2 precipitated YFP-lamin B2 S407D. 
Western blot analysis with an antibody specific for lamin B2 revealed two additional 
bands with a size of ~66 kD and ~55kD, respectively. These bands most likely 
represent degradation products as they are also detected with an antibody specific 
for GFP (data not shown). An additional band detected was also detected in the 
antibody control sample, and thus probably corresponded to the heavy chains of the 
antibody.  
For MALDI analysis, preclearing sample, immunoprecipitation sample, and antibody 
control sample were subjected to SDS-PAGE and the gel was subsequently stained 
with Coomassie staining solution (Figure 28 B). Seven bands (1-7) were cut out of 
the gel and MALDI-TOF analysis was performed. The results are listed in Table 10 in 
the appendix. The lMALDI-TOF analysis was performed in cooperation with Dr. M. 
Schnölzer, DKFZ Heidelberg. 
 
4.3 Characterization of a laminopathy causing lamin A mutant 
Zeller et al. (2006) recently published a novel mutation in the lamin A gene, a 
p.R321X nonsense mutation, found in a family with dilated cardiomyopathy. Three 
family members were heterozygous for the mutation and revealed variable degrees 
of cardiac contractile dysfunction in addition to severe rhythm disturbances. In order 
to characterize the mutation on a cellular level, explanted cardiac tissue and 
cultivated skin fibroblasts from two patients carrying this mutation were analyzed. 
Patient IV-1 required heart transplantation at the age of 34, and his sister (IV-3) 
suffers from mildly reduced left ventricular systolic function and first degree 
atrioventricular conduction block. The pedigree of the affected family is shown in the 
appendix (Figure 34).  
 
4.3.1 Downregulation of the mutant LMNA allele by nonsense-
mediated decay (NMD) 
An allele specific Taqman assay was employed to determine the ratio of wild type to 
mutant transcripts in patient samples (Table 9). In cultured skin fibroblasts of both 
patients IV-1 and IV-3, the wild type transcripts exceeded the mutant transcripts 
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about 30-fold. Similarly, the wild type transcripts were ~7- and ~9-fold higher in the 
left and right ventricular myocardium, respectively, of patient IV-1, than the mutant 
transcripts. In control fibroblasts, a wild type to mutant mRNA ratio of 304:1 was 
obtained, demonstrating negligible unspecific recognition of the wild type allele by 
the Taqman probe for the mutant allele.  
 
Table 9: Allele specific quantitation of LMNA transcripts. 
1The Δ CT value (CTwt-CTmut) at equal quantities of both alleles, as is the case in the 
genomic DNA of patient IV-1 and IV-3, was ~1. Accordingly, the 2- Δ CT values have to be 
corrected by a factor of 2. 
 
4.3.2 Biochemical characterization of cardiac tissue and skin 
fibroblasts 
In order to investigate the expression levels of wild type and mutant p.R321X protein 
a specimen of left ventricular myocardium obtained from patient IV-1 at the time of 
cardiac transplantation and cultured skin fibroblast cells from patients IV-1 and IV-3 
were analyzed by Western blotting. For control, primary skin fibroblasts obtained 
from a healthy person and cardiac muscle tissue from a patient, who underwent 
cardiac transplantation due to ischemic cardiomyopathy and harbored no LMNA 
mutation, were used. Cardiac tissue was disrupted and homogenized as described in 
Sample Allele CT Δ CT  
(CTwt-CTmut)
2- Δ CT Corrected ratio1  
wild type/mutant 
Patient IV-3 
fibroblasts 
wild type 
mutant 
28.03 
31.94 
-3.91 15.0 30.0 
Patient IV-1 
fibroblasts 
wild type 
mutant 
27.73 
31.60 
-3.87 14.6 29.2 
Patient  IV-1 
left ventricle 
wild type 
mutant 
32.86 
34.57 
-1.71 3.3 6.6 
Patient  IV-1 
right ventricle 
wild type 
mutant 
29.13 
31.35 
-2.22 4.7 9.4 
Wild type 
control 
fibroblasts 
wild type 
mutant 
27.80 
35.05 
-7.25 152.2 304.4 
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section  3.7.1 and cell lysates were subjected to SDS-PAGE. Equal protein amounts of 
control and patient cardiac tissue were loaded onto the gel as validated by 
Coomassie staining (Figure 29). Cultured skin fibroblast cells from patients IV-1 and 
IV-3 were analyzed by differential protein extraction (see  3.7.2). Western blots of 
cardiac tissue and skin fibroblasts were detected with an antibody raised against the 
amino-terminal domain of lamin A/C. No differences between the relative amounts of 
wild type lamin A/C protein could be observed, neither in the controls and in cardiac 
muscle from patient IV-1 (Figure 29 A), nor in the cytoskeletal fractions 2 and 4 of 
cultured fibroblast cells from both patients examined (IV-1 and IV-3; exemplified for 
patient IV-1, Figure 29 B). These data suggest that the single wild type LMNA allele 
in the heterozygous patient is sufficient to produce ‘normal’ quantities of lamin A/C 
protein. In agreement with the finding of down regulation of the mutant LMNA allele 
at the mRNA level, the truncated p.R321X lamin A protein with an expected 
molecular weight of ~37 kDa could not be detected in all patient tissues analyzed at 
our level of sensitivity (Figure 29 A + B).  
 
 
Figure 29: Western blot analysis of patient and control samples using an antibody 
specific for lamin A. (A) Whole cell lysate of left ventricular myocardial tissue. Coomassie 
staining (two lanes on the right), (B) Differential protein extraction of fibroblasts. Lane 1, soluble 
and extractable cytoplasmic proteins, lane 2, total cytoskeletal fraction, lane 3, high-salt and high-
detergent soluble cytoskeletal fraction, lane 4, insoluble cytoskeleton proper. 
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4.3.3 Inhibition of the proteasome uncovers the truncated 
LMNAR321X protein 
We have demonstrated that the mutant LMNA allele was significantly down regulated 
but not completely shut off. This leaves the possibility that the truncated message 
could be translated into a short-lived protein. Since such misfolded proteins are 
particularly prone to proteasomal degradation, the proteasomal function in cultured 
fibroblasts was suppressed with the proteasome inhibitor epoxomicin. The cells were 
treated for 24 hours with 100 nM epoxomicin and subjected to differential protein 
extraction. The isolated fractions 1-4 were analyzed in a Western blot by detection 
with an antibody specific for the N-terminal segment of lamin A/C. The truncated 
p.R321X protein was readily detectable in the cytoskeletal fractions 2 and 4 of 
patient IV-1 but not in control fibroblasts (Figure 30). In fibroblasts derived from 
patient IV-3, however, no truncated p.R321X protein was detected. This indicates 
that NMD may not fully prevent the synthesis of the truncated protein in patient IV-
1. Moreover, the relative amount of lamin A to lamin C in epoxomicin treated 
fibroblasts of patient IV-1 was reduced compared to control fibroblasts. The reason 
for this reduction in lamin A is at present completely elusive. 
 
 
Figure 30: Western blot analysis of detergent-extracted fractions from patient and 
control fibroblasts treated with epoxomicin using an antibody specific for lamin A. Left 
panel: patient IV-1, right panel: control patient. Lane 1, soluble and extractable cytoplasmic 
proteins, lane 2, total cytoskeletal fraction, lane 3, high-salt and high-detergent soluble 
cytoskeletal fraction, lane 4, insoluble cytoskeleton proper. 
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4.3.4 Nuclear morphology, chromatin distribution and 
localization of nuclear proteins in patient tissues 
The nuclear morphology and the distribution of nuclear proteins were examined in 
cardiac tissue of patient IV-1 and in cultured fibroblasts of patient IV-1 and IV-3 
(Figure 31). The fixed cells or tissues were labeled with a lamin A/C specific antibody 
and chromatin organization was investigated by DAPI staining. Lamin A/C staining 
patterns and nuclear morphology of patient IV-1 fibroblasts and cardiac tissue was 
indistinguishable from those obtained for the healthy controls. DNA staining revealed 
a normal heterochromatin distribution (Figure 31). 
 
 
Figure 31: Confocal sections of control fibroblasts (upper row), patient fibroblasts 
(middle row) and patient left ventricular myocardium (lower row) stained with an 
antibody specific for lamin A (shown in green). Note the typical rim staining for lamin A in 
all cells and the normal heterochromatin distribution as indicated by DAPI staining (shown in 
blue). Bars 10 μm. 
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Immunofluorescence staining of fibroblasts obtained from patient IV-1 and IV-3 for 
lamin B2, emerin, and LBR (exemplified for patient IV-1 fibroblasts; Figure 32) 
showed staining patterns indistinguishable from those obtained for healthy controls. 
The same was true for immunofluorescence studies done after treatment with 
epoxomicin for 24 hours (data not shown). 
 
 
Figure 32: Representative immunofluorescence staining of lamin B2 (upper row), 
emerin (middle row), and lamin B receptor (LBR, lower row) in control (left column) 
as well as in patient (right column) cultured fibroblasts. All images are confocal sections. 
Bars 10 μm. 
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4.3.5 Transfection of the lamin A p.R321X mutant 
In order to reveal potential toxic effects of the truncated protein on the nuclear 
morphology and chromatin distribution, an EGFP-tagged expression construct for 
both wild type LMNA and mutant p.R321X was generated. Transient transfection of 
HeLa cells with the wild type LMNA cDNA revealed a typical “rim-staining” at the 
nuclear periphery. The mutant lamin A was found to be partially targeted to the 
nucleus, where it accumulated in the nucleoplasm and, to some extent, in the 
nuclear lamina (Figure 33). Additionally, the mutant protein was distributed 
throughout the cytoplasm. The heterochromatin distribution, the nuclear shape and 
the distribution of lamin B2 and emerin appeared not to be affected by transient 
overexpression of the truncated lamin A variant.  
 
Figure 33: Transient transfection study of EGFP-tagged p.R321X in HeLa cells. Note the 
diffuse cytoplasmic and nucleoplasmic distribution of the truncated protein (green, left column) in 
transfected cells. Some mutant protein is also recruited to the nuclear lamina as indicated by the 
rim staining. Immunofluorescence stainings with antibodies specific for lamin B2 or emerin 
respectively are shown in red (middle column). DNA is detected with DAPI (blue, right column). 
All images are confocal sections. Bars 10 μm. 
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5 Discussion 
5.1 Topogenesis of lamins/lamina 
5.1.1 Role of the lamin head and tail domains in cellular 
localization 
To determine the influence of the distinct head and tail domains on lamin filament 
organization and cellular localization, human cultured cells were transfected with 
cDNAs coding for the Δ32head, headless, tailless, Δ32head/tailless, and the rod of 
human lamin B2 fused to YFP. Deletion of the head domain or the tail domain was 
essential for the formation of a dominant negative lamin mutant. Mutants with partial 
(LB2 Δ32head) or complete deletion of the head domain (LB2 headless) localized to 
the nuclear rim but nuclear shape was highly impaired. Double mutants exhibiting 
both head domain deletions and tail domain deletions (LB2 Δ32head/tailless and LB2 
rod) were effective as dominant negative mutants and their effects were almost 
identical to those of the mutants carrying only the tail deletion (LB2 tailless).  
 
Tailless lamin B2 mutants 
We could show that the lamin B2 tail domain is indispensable for targeting the 
protein to the nuclear rim and its proper integration into the nuclear envelope. 
However, it seems to be dispensable for nuclear localization. Lamin B2 mutants 
devoid of the tail domain were not only distributed throughout the cytoplasm but 
were also found in the nucleoplasm. Furthermore, tailless lamin mutants could not be 
integrated into the nuclear rim. These observations are in agreement with previous 
studies. The C-terminal tail domains of lamins contain several motifs that are 
essential for their correct localization: a nuclear localization signal (NLS) and a CAAX 
box motif, which are thought to be required for proper targeting of lamins into the 
nucleus and nuclear envelope, respectively. Although tailless lamin B2 mutants are 
devoid of the NLS a significant portion of the mutant protein localized to the 
nucleoplasm. The nuclear localization of tailless lamin B2 can be explained by the 
presence of an evolutionary conserved motif at the end of coil 2 of the α-helical rod 
domain. This motif has been shown to direct vimentin, a cytoplasmic IF protein, to 
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the nucleus when its tail domain is deleted (Rogers et al, 1995). The inability of 
tailless lamin B2 to incorporate into the nuclear lamina is suggested to be due to the 
lack of the CAAX motif. Chicken lamin B2 CAAX-less mutant proteins were reported 
to be distributed diffusely throughout the nucleoplasm (Nigg et al, 1992). B-type 
lamins are permanently farnesylated and this modification, although necessary, is not 
sufficient for anchorage at the nuclear envelope, and a prenyl receptor is required for 
this association. Two nuclear membrane proteins bind to B-type lamins in domains 
that are not deleted in any of the tail deleted lamin B2 mutants reported here, 
namely LBR (Mical & Monteiro, 1998) and LAP2β (Furukawa & Kondo, 1998). 
Although it has been concluded previously that the LBR binding domain is not 
sufficient for nuclear envelope localization of lamin B (Mical & Monteiro, 1998), 
LAP2β does appear to have an important role in lamin filament assembly (Yang et al, 
1997). We conclude from our results that the tail domain of lamin B2 contains those 
elements that are necessary for effectively guiding these lamins to the nuclear 
envelope.  
 
Lamin B2 head deletion mutants 
A major result of our study was that the lamin B2 head domain is dispensable for 
localization of the protein to the nuclear rim. Wild type lamin B2 contains in its head 
domain a highly conserved sequence. This is deleted in lamin B2 headless but not in 
lamin B2 Δ32head. Interestingly both, lamin B2 protein deleted in the N-terminal 32 
amino acids (LB2 Δ32head) and lamin B2 protein deleted in the complete head 
domain (LB2 headless) localized to the nuclear rim. It is thus clear that the 
conserved sequence in the lamin B2 head domain is dispensable for nuclear envelope 
targeting. However, nuclear shape was highly impaired by both mutants. This finding 
suggests that headless lamin B2 protein interferes with proper lamina assembly and 
thus impairs the structural function of the nuclear lamina. Several important studies 
have highlighted the role of the lamina in determining the shape of the nucleus. In 
mouse spermatocytes, nuclei are hook shaped rather than spherical, and a 
spermatocyte-specific lamin - lamin B3 – is expressed in these cells. Indeed, 
exogenous expression of lamin B3 in somatic cells resulted in their nuclei adopting a 
hook-shaped morphology (Furukawa & Hotta, 1993). Schirmer et al. (2001) 
constructed a dominant-negative mutant of lamin B1 that lacked four-fifths of the 
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rod domain (B1Δrod). This mutant was still able to self-assemble into filaments in 
vitro and, when transfected into cultured cells, was incorporated into the lamina. 
However, its incorporation into the lamina caused massive deformation of the 
nuclear envelope. In support of this, deletion of the head domain of both lamin B1 
(Ellis et al, 1997) and lamin A (Spann et al, 1997) lead to the formation of very 
fragile nuclei when used to assemble artificial nuclei using detergent extracted sperm 
nuclei in the presence of Xenopus egg extracts. 
 
5.1.2 “Mitotic” lamins  
The amino acid sequence of three phosphorylation sites of human lamin B2 and 
lamin B1 were altered and the mutated proteins were expressed in U2OS cells. The 
mutations affected three highly conserved serine residues flanking the α-helical rod 
domain. These serine residues (i.e. serine 37 and serine 405 or 407 in the human 
lamin B2 sequence; serine 23 and serine 391 or 393 in the human lamin B1 
sequence) have been shown to be phosphorylated in response to a cdc2 kinase in 
mitosis (Heald & McKeon, 1990; Nigg, 1992; Peter et al, 1990). 
If the phosphorylation of Ser-37/23, Ser-405/391, and Ser-407/393 participated in 
the active disassembly of higher order lamin associations, it would be expected that 
an amino acid exchange of these serine residues to negatively charged aspartic acid 
residues would either prohibit the integration of these mutants into the nuclear 
lamina or lead to the disassembly of the nuclear lamina. Indeed, the mutant proteins 
were not incorporated into the lamina but formed intranuclear aggregates when 
expressed in U2OS cells. Both, lamin B1 mutants and lamin B2 mutants localized to 
nuclear aggregates. The aggregates varied in size, and those observed for lamin B1 
mutants were in general smaller than mutant lamin B2 aggregates. Some of these 
aggregates appeared to be associated with the nuclear membrane whereas others 
were not as judged by confocal microscopy. Interestingly, the effect of nuclear 
aggregate formation was independent of both the position of the mutated site and 
the number of mutated sites. Early on, using polymers reconstituted in vitro from 
bacterially expressed chicken lamin B2 proteins, it could be shown that 
phosphorylation of mitotic phosphoacceptor sites caused disassembly of longitudinal 
head-to-tail polymers into dimers but not dissociation of dimers (Nigg, 1992; Peter et 
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al, 1991). A molecular description of the effects of phosphorylation on lamin 
assembly remains to be established: what is the structure of the non-helical regions 
surrounding the mitotic phosphoacceptor sites before phosphorylation and how do 
these sites change in response to phosphorylation? It is conceivable that the major 
effects on lamin disassembly are not directly mediated by the placement of negative 
charge but rather through conformational changes of the surrounding regions.  
The observed nuclear aggregates might represent a deposit for excess/surplus 
produced proteins, or proteins which might interfere/are harmful with cellular 
integrity. About the ultrastructure of the aggregates it can only be speculated. It is 
not clear whether the aggregates represent accumulations of the mutant protein or if 
they represent intranuclear membrane assemblies. Previous electron microscopic 
analysis demonstrated that the exogenous expression of CAAX-containing lamin 
proteins in Xenopus A6 cells, Xenopus oocytes, and COS-7 cells lead to the formation 
of intranuclear membrane assemblies (Prufert et al, 2004 2004). It has been shown 
that in Xenopus oocytes these intranuclear membranes are covered by single lamin 
filament layers (R. Stick, personal communication). It has been proofed to be difficult 
to solubilize intranuclear NLS-vimentin aggregates (H. Herrmann, personal 
communication) which have been shown to consist of loose protein accumulations. 
The higher solubility of “mitotic” lamin B2 mutants compared to wild type lamin B2 
would argue for intranuclear membrane assemblies.  However, as observed in 
immunofluorescence stainings with antibodies specific for inner nuclear membrane 
proteins, LBR and emerin were not localized to the nuclear aggregates. They were 
furthermore excluded from the nuclear rim at the sites of “mitotic” lamin B2 
aggregates. In contrast, Nup153 was enriched at the sites of nuclear aggregates but 
did not relocalize from the nuclear rim. These results argue against the formation of 
intranuclear membrane assemblies. It will be necessary to analyze cells expressing 
“mitotic” lamin B mutants by means of electron microscopy to clarify the 
ultrastructure of the aggregates observed.  
The structure and the mobility of lamin proteins in these aggregates is not 
characterized so far. Fluorescence recovery after photobleaching (FRAP) analysis of 
the nuclear lamina in interphase cells revealed that both lamin A and lamin B1 are 
almost immobile in the lamina (Broers et al, 1999; Daigle et al, 2001). However, in 
our study extracts from differentially extracted cells expressing mutant lamin B2 
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showed an increased solubility of mutant proteins compared to endogenous lamin B2 
suggesting a higher mobility of the proteins in the aggregates. In live cell imaging 
experiments we could show that the nuclear aggregates are rather dynamic 
structures. The aggregates fused, forming single large lamin territories. Preliminary 
data from FRAP analysis suggest a higher mobility of lamin mutants in the 
aggregates as in the nuclear lamina (data not shown). Further FRAP analysis will be 
performed to verify this observation.  
The mechanism underlying aggregate formation is yet unknown. Upon co-
transfection, aggregates of “mitotic” lamin B1 did not co-localize completely with 
“mitotic” lamin B2 aggregates but rather showed an overlap of aggregates on the 
borders. Similar results were obtained when co-expressing Xenopus NLS-vimentin 
and “mitotic” lamin B1 or “mitotic” lamin B2 protein. Xenopus NLS-vimentin formed 
nuclear dots localizing next to mutant lamin aggregates but were also found in 
separate locations. Nuclear Xenopus NLS-vimentin accumulations have been 
suggested to represent deposit structures for proteins produced in excess or proteins 
incapable of filament formation (Reichenzeller, 2002). However, in stable cell lines 
NLS-vimentin formed few and very small aggregates indicating that this ectopically 
expressed protein is recruited to specific loci within the nucleus (Bridger, 2005). The 
nuclear space occupied by NLS-vimentin has been shown to be the interchromosomal 
domain (ICD) compartment (Bridger et al, 1998). Mutant lamin aggregates were also 
clearly separated from chromatin and in close spatial proximity to vimentin-NLS 
accumulations. This suggests that both aggregates formed from mutant lamin 
proteins and NLS-vimentin accumulations are deposited in the ICD. Although all of 
the above mentioned ectopic or mutant proteins are localized to nuclear aggregates 
occupying the same nuclear space, intermingling could not be observed. Although 
the mechanism underlying aggregate formation of “mitotic” lamin B1, “mitotic” lamin 
B2, and NLS-vimentin remains elusive, our results strongly suggest the existence of 
nuclear “protein processing centers”. Their functions may relate to the prevention of 
macromolecular crowding as well as to the organization and distribution of nuclear 
proteins in general.  
In a recent study it was demonstrated that EGFP and EGFP fusion proteins inhibit 
polyubiquitination, a posttranslational modification that controls a wide variety of 
cellular processes, like activation of kinase signaling or protein degradation (Baens et 
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al, 2006). Thus proteasomal degradation of the aggregate forming mutants might be 
inhibited by the presence of their tag.  
 
5.2 Influence of lamin B mutants on the endogenous lamina 
and lamina assembly 
Several studies indicate that there might be a hierarchy of lamin-lamin associations 
at the INM. In this hierarchy, the B-type lamins are assembled into lamina filaments 
first, followed by lamin A and then by lamin C (Hutchison et al, 2001). In Xenopus 
egg extracts, recombinant lamin A is assembled at the NE of in-vitro-assembled 
sperm pronuclei only in the presence of the endogenous lamin B3, indicating that 
lamin A might be incorporated into existing B-type lamina filaments (Dyer et al, 
1999). In tissue culture cells, lamin A remains in the nucleoplasm until B-type lamin 
filaments are assembled in the telophase nuclei (Dechat et al, 2000; Moir et al, 
2000). Finally, dominant negative lamin mutants that have altered lamin-assembly 
properties have distinctively different effects on A-type and B-type lamins (Izumi et 
al, 2000; Schirmer et al, 2001; Vaughan et al, 2001) indicating that the two types of 
lamin might be incorporated into the lamina in different ways.  
 
Lamin B2 head deletion mutants 
Both lamin B2 head deletion mutants localized to the nuclear rim and did not 
influence endogenous lamin A and lamin B2 distribution. However, in cells expressing 
lamin B2 head deletion mutants nuclear shape was highly impaired. Biochemical 
fractionation showed that lamin B2 headless and lamin B2 Δ32head were more 
soluble than transfected YFP-tagged wild type and endogenous lamin B2. These 
results are in support of previous studies which suggested that the head domain is 
required for efficient lamin assembly. In vitro analysis of headless lamin mutants 
demonstrated that the mutant proteins loose their ability to associate head to tail 
(Heitlinger et al, 1992; Stuurman et al, 1996). Other support for the role of the head 
domain in lamin assembly comes from experiments of nuclei assembled in Xenopus 
extracts, in which the nuclei failed to establish a normal organization of lamin B3 in 
the presence of headless lamin mutants (Moir et al, 2000; Spann et al, 1997). In 
mammalian cells, deletion of the head domain in lamin A lead to the formation of 
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nuclear aggregates, which resulted in the disruption of endogenous lamins A/C. In 
contrast, headless lamin B1 was shown to localize to the nuclear rim without any 
detectable effect on the nuclear lamina (Izumi et al, 2000). Therefore, the large 
majority of the results obtained from experiments with headless lamins demonstrated 
that their non-helical amino-terminal head domains are required for the formation of 
the head to tail interactions necessary for normal lamin assembly. They also showed 
that the function of the head domain in filament assembly is evolutionary conserved. 
The discrepancies in the behavior of headless lamin B2 protein and headless lamin 
B1 could reflect genuine differences between lamin B2 and lamin B1. We conclude 
from our results that the head domain of human lamin B2 is necessary for efficient 
lamin assembly. It is however not possible to decide from light microscopy data 
whether the shortened lamin B2 is only targeted correctly but not assembled 
properly, or if the head domain of lamin B2 is not engaged in lamina formation but 
the organization of other factors within the nuclear envelope.  
 
Tailless lamin B2 mutants 
The tailless lamin mutants LB2 tailless, LB2 Δ32head/tailless, and LB2 rod did not 
localize to the nuclear rim and were distributed throughout the cytoplasm and the 
nucleoplasm. Immunofluorescence stainings with antibodies specific for lamin A and 
lamin B2 showed that the tailless lamin B2 proteins were not incorporated into the 
nuclear rim. However, endogenous lamin A and at least a portion of endogenous 
lamin B2 protein resided in the nuclear lamina. These findings indicate that a 
functional lamina can be assembled in the presence of tail deleted lamin B2 mutants. 
In cells expressing lamin B2 tailless, a fraction of lamin A co-localized with the 
mutant lamin B2 in the cytoplasm. It is conceivable that lamin B2 tailless forms 
heteropolymers with lamin A already in the cytoplasm and thus restrains it from 
being transported into the nucleus. However, it is also conceivable that LB2 tailless 
protein in the nucleus recruits lamin A from the nuclear lamina (see below) and is 
transported as heteromeric complex into the cytoplasm. Both possibilities suggest an 
important role of the lamin B2 head domain in heteropolymer formation and in the 
latter case also in the recruitment of lamin A from the nuclear envelope.  
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“Mitotic” lamins 
The effect of lamin proteins mutated in the mitotic phosphoacceptor sites on the 
endogenous lamina has been analyzed by confocal laser scanning microscopy with 
antibodies specific for lamin A and lamin B2. Endogenous lamin A was localized at 
the nuclear rim but was also co-localizing with “mitotic” lamin B1 and “mitotic” lamin 
B2 at nuclear aggregates. Endogenous lamin B2 remained unaffected by the 
expression of mutant lamin B1 and localized at the nuclear rim. These findings are 
consistent with the fact that several dominant negative A-type and B-type lamin 
mutants that form nucleoplasmic aggregates cause the relocation of A-type lamins 
from the NE to the aggregates but do not affect the distribution of B-type lamins 
(Izumi et al, 2000; Vaughan et al, 2001). These findings suggest distinct differences 
in the organization of A-type and B-type lamins within lamina filaments. One 
explanation for this difference is related to the way in which the different lamin types 
are anchored to the nuclear envelope. B-type lamins remain farnesylated throughout 
their lifespan (Moir et al, 1995). The farnesylated modification is important but not 
sufficient for targeting and anchoring the protein to the INM, and a prenyl receptor is 
required for this association. In addition, the integral membrane protein LAP2β also 
binds specifically to B-type lamins (Foisner & Gerace, 1993). Therefore it seems likely 
that B-type lamins are anchored to the nuclear envelope by interactions with integral 
membrane proteins at two separate points along the axis of the lamin dimer. In 
contrast, A-type lamins are not anchored through their tail domains and although 
there are integral membrane proteins that bind to A-type lamins (LAPs 1A, 1B, and 
emerin) these proteins also bind to B-type lamins (Gruenbaum et al, 2003). 
Therefore, specific associations between A-type lamins and integral membrane 
proteins may either not occur or may be less stable than associations between 
integral membrane proteins and B-type lamins. In light of the large number of 
integral membrane proteins, many more proteins may bind at the same time. Hence 
these are all preliminary speculations and it will be important in the future to define 
the network of interactions that tether lamins to the nuclear envelope. It has been 
suggested previously that dominant negative lamin mutants exert their effects by 
trapping lamins that are in a dynamic equilibrium between filamentous and soluble 
nucleoplasmic state (Ellis et al, 1997; Schmidt et al, 1994). Presumably in somatic 
cells A-type lamins are more mobile than B-type lamins for the reasons stated above. 
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Indeed, a significant proportion of A-type lamins is readily extracted from the lamina 
of a range of cell lines, whereas B-type lamins are completely insoluble (Hutchison et 
al, 2001). Thus, a combination of the greater affinity of A-type lamins for the mutant 
proteins and the greater solubility of A-type lamins means that these proteins are 
readily sequestered from the lamina to nucleoplasmic lamin aggregates, whereas B-
type lamins are not.  
In cells expressing “mitotic” lamin B2, the lamin B2 antibody staining was visible as 
rim-like structures surrounding the intranuclear aggregates. This effect might be due 
to sterical hindering of the lamin B2 antibody. It is conceivable that the lamin B2 
antibody used first binds massively on the surface of the nuclear aggregates and 
thus hinders antibody penetration into the aggregates. 
Biochemical fractionation showed that a portion of “mitotic” lamin B2 protein is more 
soluble as wild type lamin B2 protein. The solubility properties of endogenous lamin 
B2 were not influenced by the expression of “mitotic” lamin B2 mutants. This 
indicates that “mitotic” lamin B2 mutant proteins probably do not form 
heteropolymers with wild type lamin B2 due to their “mitotic” signal. We conclude 
from our results that a lamina structure can be assembled in the presence of both 
“mitotic” lamin B1 and “mitotic” lamin B2, however, “mitotic” lamin B2 segregates 
from endogenous lamin B2 protein.  
 
5.3 Organization of the nuclear envelope 
The lamina has important functions in anchoring the elements of the NE to their 
correct position, and the lamins as major elements of the lamina are crucial in this 
process. Anchorage functions of the lamins include the spacing of NPCs and the 
recruitment of proteins to the INM (Lenz-Bohme et al, 1997). In Xenopus sperm 
pronuclei B-type lamins interact with the nuclear pore protein nucleoporin 153 
(Nup153). Moreover, disruption of lamina filaments with dominant negative lamin 
mutants causes a selective loss of Nup153 from NPCs (Smythe et al, 2000). Nup153 
is located within the nucleoplasmic ring of NPCs (Walther et al, 2001). Hence it is in 
good proximity to lamin filaments and therefore it was proposed that lamina 
filaments interact with the nucleoplasmic ring of NPCs via Nup153, thereby anchoring 
NPCs within the NE. We could show that in cells expressing “mitotic” lamin B2 
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mutants Nup153 was accumulated at sites of membrane associated aggregates 
formed by the mutant protein. This suggests that the lamina filament structure 
necessary for correct positioning of the NPCs is interrupted by the presence of 
“mitotic” lamin B2 causing the observed rearrangement of Nup153.  
Emerin and LAP1 are thought to be anchored at the INM through interactions with 
lamin A/C (Manilal et al, 1996; Nagano et al, 1996; Senior & Gerace, 1988; Sullivan 
et al, 1999). In contrast, members of the LAP2 family of INM proteins and LBR are 
believed to be anchored at the INM through interactions with lamin B (Harris et al, 
1995; Ye & Worman, 1994). However, it was shown recently, that CAAX motif 
deleted lamin B protein fractionated independently of LBR, indicating that these two 
proteins do not bind directly to each other (Mical & Monteiro, 1998). We could show 
that deletion of the head or tail domain of lamin B2 does not interfere with proper 
emerin localization. In contrast, LBR was partially localized to the ER by the 
expression of head deleted lamin B2 mutants. Deletion of the lamin B2 head domain 
may lead to a weakening of a structural support network and thus LBR may either be 
partially retained in the ER after synthesis or be partially redistributed from the 
nuclear envelope to the ER. Further experiments will be needed to clarify whether 
the lamin B2 head domain is involved in a direct interaction with LBR. In cells 
expressing “mitotic” lamin B2 mutants, both emerin and LBR localized to the nuclear 
rim. However, LBR and emerin distribution was interrupted at sites where membrane 
associated “mitotic” lamin B2 aggregates occurred. These results clearly demonstrate 
that proper lamin filament assembly is a prerequisite for proper nuclear envelope 
organization.  
 
5.4 The role of lamins in DNA replication 
It is widely accepted that lamins play a role in DNA replication, but the mechanism 
how lamins take part in this process is elusive. Several laboratories have 
demonstrated that nuclear lamin proteins are essential for DNA replication in 
Xenopus egg extracts. Without lamin proteins, nuclear membranes assemble around 
Xenopus sperm chromatin but do not initiate replication. This has been observed 
when lamin-free nuclei are assembled either from extracts that were 
immunodepleted for lamins (Jenkins et al, 1993; Meier et al, 1991; Newport et al, 
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1990) or by supplementing extracts with dominant negative, i.e. headless lamin 
mutants (Ellis et al, 1997; Spann et al, 1997). When purified lamin B (but not lamin 
A) is re-added to depleted extracts, DNA replication is initiated, indicating that lamins 
might have a direct role in DNA replication (Goldberg et al, 1995). Further 
experiments employing dominant negative lamin mutants showed that intranuclear 
lamin aggregates formed by the mutant proteins had recruited endogenous B-type 
lamins to the aggregates as well as proliferating cell nuclear antigen (PCNA) and 
replication factor complex (RFC) (Ellis et al, 1997; Moir et al, 2000; Spann et al, 
1997). This strongly suggests that lamins are involved in the elongation phase of 
DNA replication. In somatic cells, similar mutants still formed intranuclear 
aggregates. However, whereas A-type lamins were recruited to the aggregates, B-
type lamins were not. In this case PCNA and prereplication complex Mcm proteins 
localized to mutant lamin aggregates demonstrating that, in mammalian cells, the 
association of nuclear proteins with dominant negative lamin mutants is not 
restricted to proteins exclusively present at the replication fork. Furthermore, DNA 
replication was not inhibited by the presence of the mutant proteins (Izumi et al, 
2000). The interaction of “mitotic” lamin B2 mutant with PCNA is consistent with the 
observation of Moir et al. (Moir et al) and Izumi et al. (2000) that B-type lamins 
associate with late replication centers. Further studies are needed to clarify whether 
DNA replication is influenced by the presence of “mitotic” lamin proteins and whether 
other replication proteins are recruited to the intranuclear aggregates.  
Although it appears clear that B-type lamins associate with sites of DNA replication 
and replication proteins, the role of lamins in DNA replication is still far from being 
resolved. The prospect of using RNAi to knock down the expression of specific lamins 
in mammalian cells probably provides the best opportunity to address this important 
issue (Harborth et al, 2001).  
 
5.5 Role of lamins in chromatin organization 
Due to the intimate spatial relationship between lamins and chromatin, it has been 
suggested that chromosomes are anchored, at least to some extent by the nuclear 
lamina. Indeed, all lamin subtypes have affinity for chromosomes, chromatin and/or 
DNA (Mattout-Drubezki & Gruenbaum, 2003). Several studies indicate that lamins 
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influence chromosome position in interphase (Bridger et al, 2007; Malhas et al, 
2007). Further support for a role of lamins in chromatin organization comes from 
studies in laminopathy cell lines whereby chromatin is disorganized and observed 
coming away from the nuclear periphery (Columbaro et al, 2005; Filesi et al, 2005; 
Sewry et al, 2001). It is, however, not clear how changes in chromosome positioning 
take place and what the consequences for genome function are, i.e. gene 
expression. It is plausible that lamins are not purely anchorage sites for the genome 
but that they are involved in signaling pathways. In diseased cells these pathways 
may be perturbed, eliciting a reorganization of the genome and thereby changing the 
normal status of the cells. Heterochromatin, including centromeres, telomeres and 
repetitive DNA, is preferentially positioned near the nuclear envelope. Several studies 
suggest that the nuclear periphery may be a repressive environment for transcription 
of many genes (Mattout-Drubezki & Gruenbaum, 2003). Indeed, a growing number 
of transcription factors, including the transcriptional repressor germ-cell-less (GCL), 
Oct-1 and pRb either co-localize with the nuclear lamina or interact with proteins 
anchored to the lamina (Shaklai et al, 2007). Despite of this circumstantial evidence, 
still little is known about the molecular mechanisms responsible for nuclear-lamina 
dependent gene regulation. Although expression of lamin B2 deletion mutants in 
U2OS cells did not influence overall chromatin distribution as revealed by DAPI 
staining, it is possible that gene expression is altered by their presence. This issue 
should also be addressed in cells expressing “mitotic” lamin mutants, as chromatin 
distribution is massively affected by the formation of “mitotic” lamin nuclear 
aggregates. Lamin mutants together with the remarkable sensitivity of gene chip 
technology may provide the means to directly test if normal lamin organization is a 
requirement for transcription.  
 
5.6 Lamins in ES cells 
Only a few aspects of nuclear architecture have been characterized in detail in ES 
cells, but cursory observations indicate that many nuclear features, including the 
nuclear lamina, the nucleolus, heterochromatin structure and nuclear speckles, 
undergo morphological changes during the differentiation process (Meshorer & 
Misteli, 2006). In both mouse and human ES cells, lamin B1 and lamin B2 are 
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expressed in high levels (Constantinescu et al, 2006). In contrast, ES cells do not 
express A-type lamins. The absence of lamin A even serves as a specific stem cell 
marker in both mouse and human ES cells (Constantinescu et al, 2006). So far, there 
is no report about exogenous expression of lamins in ES cells and the influence of 
lamin mutants on cellular integrity. We have expressed YFP-lamin B1 and YFP-lamin 
B2 in mouse ES cells. As expected, both proteins localized to the nuclear periphery. 
In some cells transiently transfected with the respective expression plasmids, the 
nuclear envelope appeared as a rather thick structure. The variation of the thickness 
of the nuclear envelope might be explained by different expression levels of the 
proteins. It could further be shown that cells stably expressing YFP-lamin B1 and 
lamin B2 respectively, did not have a higher tendency to differentiate than 
untransfected cells. This indicates that exogenous expression of YFP-lamin B1 and 
YFP-lamin B2 fusion proteins does not influence the stem cell status of the cells. ES 
cells stably expressing YFP-lamin B1/B2 may provide the means to follow possible 
changes in lamina morphology during ES cell differentiation by time-lapse 
microscopy.  
Expression of lamin B2 deletion mutants in mouse ES cells showed similar effects as 
those observed in U2OS cells. Both the YFP-lamin B2 Δ32head and YFP-lamin B2 
headless protein integrated into the nuclear rim. In some cells small aggregates 
along the nuclear envelope or invaginations of the nuclear lamina were observed. In 
contrast, YFP-lamin B2 tailless and YFP-lamin B2 rod were diffusely distributed 
throughout the cytoplasm and the nucleoplasm. These results suggest that lamin 
proteins are similarly processed and assembled into the nuclear lamina in both 
differentiated and ES cells. To date we can not make any statement about the 
influence of lamin B2 deletion mutants on differentiation.  
ES cells are a valuable tool for further cell biological studies. They can be 
differentiated into all specialized cell types found in the adult mouse and exhibit and 
maintain a normal diploid complement of chromosomes. A complete characterization 
of the nuclear landscape in pluripotent ES cells will be a useful basis for a cell-
biological understanding of these cells.  
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5.7 Identification of novel putative lamin interaction partners 
With co-immunoprecipitation and mass spectrometry-based methodology we have 
identified new proteins potentially interacting with the soluble lamin B2 protein 
mutated from serine to aspartic acid in mitotic phosphorylation sites. Among the 
putative “mitotic” lamin B2 partners were found several ribosomal proteins (L4, L17, 
L18, S5, and S9). Ribosomal proteins are synthesized in the cytoplasm and are 
imported into the nucleolus where they, together with rRNA, are assembled to the 
ribosomal subunits. On their way to the nucleolus they might be trapped by the 
“mitotic” lamin B2 aggregates. Immunofluorescence stainings with antibodies specific 
for the ribosomal subunits could give further proof of this interaction. 
Another putative “mitotic” lamin B2 interaction partner was identified as the heat 
shock protein 70 (Hsp70) family member mortalin which is heat-uninducible. 
Members of the Hsp70 family have been reported to be localized in almost all 
subcellular compartments including the nuclear matrix (Jethmalani & Henle, 1997; 
Pouchelet et al, 1983). Moreover, a recent study suggested that Hsp70 may play a 
role in the protection of nuclear lamins within the nuclear matrix (Willsie & Clegg, 
2002). All Hsps70, regardless of location, bind proteins, particularly unfolded ones. 
The molecular chaperones of the Hsp70 family recognize and bind to nascent 
polypeptide chains as well as partially folded intermediates of proteins preventing 
their aggregation and misfolding. The binding of ATP triggers a critical 
conformational change leading to the release of the bound substrate protein (Fink, 
1999). The universal ability of Hsp70 to undergo cycles of binding to and release 
from hydrophobic stretches of partially unfolded proteins determines their role in a 
great variety of vital intracellular functions such as protein synthesis, protein folding 
and oligomerization and protein transport. Mortalin is the major mitochondrial protein 
and it plays a central role in the elaborate translocation system for efficient import 
and export of proteins (Kaul et al., 2007). The biological function of mortalin is not 
restricted to its mitochondrial locale. Subcellular fractionation and 
immunofluorescence microscopy have revealed that mortalin is not only present in 
mitochondria but also in other extra-mitochondrial sites (Ran et al, 2000). Mortalin 
might keep “mitotic” lamin B2 in aggregates, thus preventing its refolding and 
assembly to its native oligomeric state.  
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It was recently suggested that mortalin is a regulator of oxidative stress and 
apoptosis, and contributes to aging and old-age pathologies (Kaul et al, 2007). 
Interestingly, overexpression of mortalin resulted in lifespan extension of normal 
human fibroblasts (Wadhwa et al, 2005). Hsp70F siRNA caused reduction in C. 
elegans lifespan and early appearance of progeria-like phenotype and age pigments 
(Yokoyama et al, 2002). So far nothing is known about a role of Hsp70/mortalin in 
HGPS, a disease caused by a mutation in the lamin A gene, which is characterized by 
accelerated aging. Whether this interaction is functional has to be tested by the use 
of different antibodies specific for mortalin.  
Beside the above mentioned putative “mitotic” lamin B2 partners, other proteins 
were identified with which interaction seems very unlikely. Further experiments will 
be necessary to verify these interactions and to reduce unspecific interactions. One 
attempt would be to increase the buffer stringency and/or to perform the extraction 
of the cells in two steps, with the first one removing all cytoplasmic proteins and thus 
reducing cytoplasmic impurities. Furthermore, antibodies specific for the respective 
proteins will be needed to verify putative interactions by microscopical and 
biochemical methods.  
 
5.8 Laminopathy 
Transcripts with premature termination codons are rapidly degraded by NMD, if the 
premature stop locates 50-55 nucleotides 5’ of a splicing-generated exon-exon 
junction (Nagy & Maquat, 1998). NMD is considered to be a surveillance pathway to 
prevent accumulation of potentially harmful truncated proteins and to properly 
regulate the expression of alternative splice products (Maquat, 2005). In a growing 
number of studies, modulating and protecting effects of NMD on the phenotype of 
hereditary disorders have already been demonstrated (Holbrook et al, 2004). 
Here, a p.R321X nonsense mutation in the LMNA gene discovered in a family with 
cardiac conduction system disease and dilated cardiomyopathy was examined by 
immunhistochemistry, immunoblotting and quantitative PCR analysis. The mutation 
was most likely responsible for the disease for four reasons: i) the mutation clearly 
segregated with the disease: among eight family members examined, three 
members were affected and mutation carriers, while five members were healthy and 
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exhibited the wild type genotype; ii) screening of 434 control individuals only 
revealed the wild type genotype; iii) the mutation is not listed as a polymorphism in 
public databases, despite extensive screening of LMNA in many laboratories; iv) 
mutation screening of 24 additional known or novel candidate genes for DCM in 
patient III-5, including those for β-myosin heavy chain (MYH7), cardiac myosin 
binding-protein C (MYBPC-3) and cardiac troponin T (TNNT2), did not reveal extra 
mutations (Zeller et al, 2006). 
Since the p.R321X nonsense mutation resides within the sixth of twelve LMNA exons, 
it was a likely target for NMD. In fact, quantitative analysis of LMNA transcripts in 
myocardial tissue and cultured fibroblasts clearly indicated significant downregulation 
of the mutant allele by NMD. Correspondingly, a truncated LMNA protein could not 
be detected at standard sensitivity of Western blotting, neither in myocardial tissue, 
nor in cultivated patient fibroblasts. Moreover, no indication of gross nuclear 
abnormalities or an aberrant cellular distribution of lamin A/C or its interaction 
partners LBR, emerin and lamin B2 could be observed: nuclei exhibited a normal 
ovoid shape, the heterochromatin appeared to be distributed normally, and all 
proteins investigated were properly targeted to the nuclear envelope. Similar 
observations of normal nuclear morphology and protein distribution have been made 
in a large number of patients heterozygous for missense mutations in the LMNA 
gene. In contrast, cells obtained from patients harbouring other LMNA mutations 
displayed a spectrum of nuclear abnormalities such as excess lobulation, extra 
nuclear speckles or even disruption of the nuclear membrane as well as dislocation of 
lamin A/C and associated proteins (Sylvius & Tesson, 2006). In a recent study, a 
comparable LMNA nonsense mutation, p.Y259X, was discovered in a heterozygous 
patient who suffered from autosomal dominant limb-girdle muscular dystrophy 
associated with conduction disturbances (LGMD1B) (Muchir et al, 2003). This 
mutation resided in the same region of lamin A/C’s central α-helical coiled-coil rod 
domain, i.e. coil 2B, as the nonsense mutation described here. Like in our study, the 
heterozygous patient displayed normal nuclear morphology and protein distribution. 
In contrast, a newborn homozygous for the respective mutation died at birth. Cells of 
this patient displayed aberrant lobulation of nuclei and absence of lamin A/C and 
several of its interaction partners. Apparently, the wild type allele was sufficient in 
the heterozygous situation to prevent the dramatic phenotype and the cellular 
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abnormalities documented in the homozygote. The authors proposed 
haploinsufficiency as a likely explanation for the LGMD1B phenotype of the 
heterozygote, as they detected reduced levels of wild type lamin A/C in the affected 
patient. Haploinsufficiency, however, is not a likely explanation for the cardiac 
phenotype in patients analyzed in this study, as no obvious reduction in the absolute 
amount of wild type lamin A/C protein both in cardiac tissue and in cultured patient 
fibroblasts was observed. 
Instead, insufficient NMD as the most likely reason for the observed disease 
phenotype is proposed. It was demonstrated a significantly reduced amount of 
mutant LMNA mRNA in both cardiac tissue and cultivated fibroblasts of affected 
patients. Although the mutant protein could not be detected in these specimens, the 
truncated protein was readily detectable after inhibition of the proteasomal protein 
degradation pathway in cultured fibroblasts of the more severely affected patient. 
Even though any obvious changes in nuclear shape or distribution of major inner 
nuclear membrane proteins such as emerin and LBR were not observed, a potential 
dominant negative effect of this mutant protein is likely to be responsible for the 
development of cardiomyopathy in the patients analyzed. Interestingly, the truncated 
protein was not detectable in another patient harbouring the mutation after 
treatment with epoxomicin at the level of sensitivity employed here, suggesting a 
more effective NMD and/or proteasomal degradation of the truncated mutant protein 
in this patient. Correspondingly, the disease phenotype in this patient is markedly 
less pronounced. 
The question why patients with mutations in the LMNA gene develop distinct disease 
phenotypes, despite the lack of readily detectable nuclear abnormalities, still awaits a 
conclusive answer (Sylvius & Tesson, 2006). Presumably, gross structural 
abnormalities are not the primary pathogenic event in various types of 
laminopathies, but rather a reflection of disturbances in the more subtle regulatory 
functions of lamin A/C. A possible clue to explain the cardiac phenotype in the 
patients analyzed in this study may be derived from apparent tissue-dependent 
differences in the efficiency of NMD. A relatively weak reduction of mutant transcripts 
was observed in the left and right myocardium as compared to skin fibroblasts which 
displayed an up to 5-fold stronger reduction of mutant transcripts. It may therefore 
be suspected that NMD is not efficient enough in affected tissues to prevent the 
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deleterious effects of the expressed mutant p.R321X allele. Because of the lifelong 
high stress and intricate mechanical coupling of myocytes, the myocardium is 
apparently an especially critical tissue and, hence, particularly prone to disturbances 
by even weak cellular imbalances. 
In summary, a family with DCM and conduction system disturbances most likely due 
to a nonsense mutation in the lamin A/C gene was described. It is proposed that 
NMD, though clearly measurable, cannot completely prevent the expression of 
truncated lamin A which may negatively interfere with structural and/or regulatory 
functions of lamin A/C, thus leading to the disease phenotype. 
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7 Abbreviations 
aa amino acid 
Acc. No. accession number 
APS ammonium persulfate 
BSA bovine serum albumin 
cDNA complementary DNA 
DAPI 4’, 6-diamidin-2’-phenylindol-dihydrochloride 
DCM dilated cardiomyopathy 
ddH2O double distilled water 
DMEM Dulbeccos modified Eagle Medium 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP 2’-deoxyribonucleoside 
DTT dithiothreitol 
E. coli Escherichia coli 
ECFP enhanced cyan fluorescent protein 
ECL electro-chemo luminescence 
EDTA ethylendiaminotetraacetate-disodium salt 
EGFP enhanced green fluorescent protein 
EGTA ethylenglycoltetraacetate 
EDMD Emery-Dreifuss muscular dystrophy 
ER endoplasmatic reticulum 
EYFP enhanced yellow fluorescent protein 
FCS fetal calf serum 
H2A histone H2A 
HGPS Hutchinson-Gilford progeria syndrome 
IF immunofluorescence 
INM inner nuclear membrane 
IP immunoprecipitation 
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kDa kilo Dalton 
LA/C lamin A/C 
LB “Luria Bertani”, full medium for bacteria 
LB1 lamin B1 
LB2 lamin B2 
LBR lamin B receptor 
LMNA lamin A gene 
MCS multiple cloning site 
MOPS morpholinepropanesulfonic acid 
mRNA messenger ribonucleic acid 
NLS nuclear localization sequence 
NMD nonsense mediated decay 
NPC nuclear pore complex 
ONM outer nuclear membrane 
PBS phosphate buffered salt solution 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PVDF phenylmethylsulfonylfluoride 
rpm rotations per minute 
RT room temperature 
RZPD German Resource Center for Genome Research 
SDS sodium dodecyl sulphate 
Tris N, N, N-tris[hydroxymethyl]aminomethan 
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8 Appendix 
 
Sample Acc. Nr. Protein Descriptiom Protein 
score 
Protein 
Mass 
matches
1 gi|31621305 leucine-rich PPR motif-containing protein 1767 159003 40
gi|27436951 lamin B2 1297 67762 292 
gi|14595132 Raichu404X 218 85646 5
gi|27436951 lamin B2 1143 67762 26
gi|12653415 Heat shock 70kDa protein 9 (mortalin) 1045 73967 20
3 
gi|14595132 Raichu404X 232 85646 6
gi|27436951 lamin B2 583 67762 17
gi|14595132 Raichu404X 234 85646 8
gi|425518 anti-colorectal carcinoma heavy chain 66 51254 3
gi|5031753 heterogeneous nuclear ribonucleoprotein H1 55 49484 3
4 
gi|1710248 protein disulfide isomerase-related protein 5 49 46512 1*
gi|27436951 lamin B2 281 67762 14
gi|34234 laminin-binding protein 204 31888 8
gi|16579885 ribosomal protein L4 168 47953 8
gi|425518 anti-colorectal carcinoma heavy chain 120 51254 5
gi|2695641 mammary tumor-associated protein INT6 68 52443 3
gi|21361809 RNA binding motif protein, X-linked-like 1 62 42173 1*
5 
gi|870743 heterogeneous nuclear ribonucleoprotein D 43 30523 3
gi|27436951 lamin B2 911 67762 24
gi|28336 mutant beta-actin (beta'-actin) 200 42128 6
gi|1706611 Elongation factor Tu, mitochondrial precursor (EF-Tu) 120 49852 3
gi|16579885 ribosomal protein L4 66 47953 3
6 
gi|4506649 ribosomal protein L3 isoform a 39 46365 1*
gi|27436951 lamin B2 282 67762 6
gi|4506607 ribosomal protein L18 189 21735 3
gi|14141193 ribosomal protein S9 163 22635 6
gi|14595132 Raichu404X 139 85646 3
gi|13904870 ribosomal protein S5 98 23033 3
gi|4506617 ribosomal protein L17 79 21611 2
gi|403009 PHAPII (Putative HLA DR Associated Protein II) 79 32084 1*
gi|23308579 unactive progesterone receptor, 23 kD 63 18971 1*
7 
gi|793843 ribosomal protein L29 44 17713 1*
Table 10: List of proteins identified with MALDI-TOF. (*) a single sequenced peptide is not 
regarded as a explicit proof for a definite identification. Protein scores greater than 78 are 
significant. 
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Figure 34: Pedigree of the affected family with the nonsense mutation CGA>TGA in 
codon 321 (pR321X) of the LMNA gene. Open and black symbols represent unaffected and 
affected individuals, respectively. (+) and (-) symbols indicate presence and absence of the 
mutation, respectively. Slanted bars denote deceased individuals. Deceased family members 
considered affected died of sudden cardiac death at the age of 48 (I-1), 59 (II-3) and 49 (II-5). 
